A role for Shh and Bmp4 in regulating the dorsal-ventral patterning of the developing pharyngeal region by Szpak, Alex
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
8-14-2019 9:30 AM 
A role for Shh and Bmp4 in regulating the dorsal-ventral patterning 
of the developing pharyngeal region 
Alex Szpak 
The University of Western Ontario 
Supervisor 
Drysdale, Thomas A. 
The University of Western Ontario 
Graduate Program in Biology 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Alex Szpak 2019 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Developmental Biology Commons 
Recommended Citation 
Szpak, Alex, "A role for Shh and Bmp4 in regulating the dorsal-ventral patterning of the developing 
pharyngeal region" (2019). Electronic Thesis and Dissertation Repository. 6673. 
https://ir.lib.uwo.ca/etd/6673 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
ii 
 
Abstract 
     The pharynx is crucial to the survival of all vertebrates since it facilitates respiration by 
connecting the nasal and oral cavity to the larynx and digestion by connecting the oral 
cavity to the esophagus. The developing pharyngeal region displays dorsoventral 
patterning, and currently there is little information identifying the underlying mechanisms 
that regulate this patterning. This is in part due to the complexity of the developing 
pharyngeal region that requires contributions from all three germ layers along with neural 
crest cells. The expression profiles of Sonic Hedgehog (Shh) and Bone Morphogenetic 
Protein 4 (Bmp4) adjacent to the developing pharyngeal region are reminiscent of their 
expression around the developing neural tube where they regulate dorsoventral patterning. 
By pharmacologically altering these signalling pathways I was able to support the 
hypothesis that the correct dorsoventral gene expression pattern observed in the developing 
pharyngeal region is regulated by opposing gradients of Shh and Bmp4. 
 
Keywords: Sonic Hedgehog, Bone Morphogenetic Protein 4, hand1, pharyngeal region, 
Xenopus laevis 
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Summary for Lay Audience 
     The pharynx is the part of the throat that connects the mouth and nasal cavity to the 
larynx and esophagus. The purpose of the pharynx is to facilitate respiration by 
connecting the mouth and nasal cavity to the larynx and allow digestion by connecting 
the mouth to the esophagus. The developing pharyngeal region can be observed on the 
lateral side of vertebrate embryos just below the developing head and can be identified by 
a series of tissue outgrowths called pharyngeal arches. During early development, the 
pharyngeal region displays patterning of genes along the anteroposterior axis (front to 
back) and dorsoventral axis (top to bottom). The signaling molecule retinoic acid 
regulates the patterning of genes along the anteroposterior axis, however, the signaling 
molecules that regulate the gene pattern along the dorsoventral axis remains unknown. 
The main aim of this thesis is to uncover those signaling molecules that regulate the 
dorsoventral patterning of the developing pharyngeal region. The signaling molecules 
Sonic Hedgehog (Shh) and Bone Morphogenetic Protein 4 (Bmp4) have been shown to 
regulate the dorsoventral patterning of the neural tube and are expressed later in 
development on the dorsal and ventral sides of the developing pharyngeal region, 
respectively. Therefore, I hypothesized that Shh and Bmp4 work in opposing gradients to 
pattern genes along the dorsoventral axis of the developing pharyngeal region. The 
hypothesis was tested by chemically inhibiting or activating Shh and Bmp4 signaling, 
staining the mRNA of genes located within the developing pharyngeal region and 
assessing the localization of the genes’ expression domains along the dorsoventral axis 
following treatment of the Xenopus laevis embryos. The results were able to support the 
hypothesis that the correct gene expression along the dorsoventral axis of the developing 
pharyngeal region is regulated by opposing gradients of Shh and Bmp4.   
iv 
 
Co-authorship 
     The initial observations that Shh signalling was regulating the dorsoventral patterning 
of the developing pharyngeal region in X. laevis was investigated by Kevin Fan and Dr. 
Thomas A. Drysdale.  I have personally performed all of the writing and experiments 
defined within this thesis.  Dr. Drysdale is attributed with co-authorship of this thesis due 
to his supervision, assistance in designing experiments, examining data, and editing the 
thesis. 
  
v 
 
Acknowledgements 
     I would like to first thank my supervisor, Dr. Thomas Drysdale, for taking me on as a 
fourth-year research project student and introducing me to the developmental biology field, 
and the many benefits of using Xenopus laevis as model organisms.  Throughout my fourth-
year and master’s project Tom has been very supportive, encouraging, inspiring and 
fostered my growing interest in the developmental biology field, allowing me to learn many 
essential laboratory techniques, and to become a better student.  I am grateful for all the 
time, effort, patience, and wisdom that he has devoted to me while in his laboratory.  These 
are just a few of the reasons why I decided to stay to continue my studies at Western 
University and complete a master’s project.  I have gained so many life and science skills 
from my time as one of Dr. Drysdale’s students. 
     I would next like to thank the professors that provided valuable feedback, assistance, 
and criticism throughout my time as a master’s student.  First, I would like to thank my 
advisory committee, Dr. Sashko Damjanovski, and Dr. Anthony Percival-Smith for their 
incredible feedback, and criticism during committee meetings.  I would like to thank fellow 
lab members Victoria Deveau, and Lucimar Teodoro for assistance with lab experiments, 
and advice for troubleshooting and learning new protocols.  I would also like to additionally 
thank Dr. Sashko Damjanovski again for reviewing this thesis before its submission.  And 
lastly, I would like to thank my parents for all the endless support they have given me 
throughout my time as a graduate student. 
     The funding for this thesis project, and opportunity to present at multiple conferences 
was provided by Western University, Department of Biology, NSERC, and Children’s 
Health Research Institute.  I would also like to thank the Collaborative Program in 
Developmental Biology for providing funding allowing me to present at the 2018 
International Xenopus Conference. 
  
vi 
 
Table of Contents 
 Page 
Abstract ...................................................................................................................... ii 
Summary for Lay Audience ....................................................................................... iii 
Co-Authorship............................................................................................................ iv 
Acknowledgements .................................................................................................... v 
Table of Contents ....................................................................................................... vi-viii 
List of Tables ............................................................................................................. ix 
List of Figures ............................................................................................................ x-xii 
List of Abbreviation ................................................................................................ xiii-xiv 
 
Chapter 1: Introduction 
1.1 Xenopus laevis as a model for development ................................................. 1-3 
1.2 Early embryonic development of the pharyngeal region .............................. 3-9 
1.3 Axial Patterning in the embryo ..................................................................... 10-13 
1.4 Sonic hedgehog (Shh) signalling .................................................................. 14-17 
1.5 Bone morphogenetic signalling 4 (Bmp4) signalling ................................... 18-19 
1.6 Regional dorsoventral pattern within the developing pharyngeal 
complex ............................................................................................................... 20-24 
1.6.1 Ventral pharyngeal region marker .................................................... 20-21 
1.6.2 Intermediate pharyngeal region markers .......................................... 21-22 
1.6.3 Dorsal pharyngeal region markers ................................................... 22-24 
1.7 CRISPR/Cas9 Genome Editing Technology ................................................ 25-27 
vii 
 
1.8 Purpose of the research ................................................................................. 28-33 
Chapter 2: Materials and Methods 
2.1 Generation of X. laevis embryos ................................................................... 34 
2.2 Shh activator and inhibitor ............................................................................ 34 
2.3 Bmp4 inhibitors ............................................................................................ 34-35 
2.4 Embryo fixation ............................................................................................ 35 
2.5 Plasmid transformations to prepare probes ................................................... 35 
2.6 Restriction digest to prepare probes .............................................................. 35-37 
2.7 Probe synthesis for in situ hybridization ....................................................... 38 
2.8 Whole-mount in situ hybridization ............................................................... 38-39 
2.9 Single guide RNA (sgRNA) of the hand1 gene synthesis ............................ 39-43 
2.10 Microinjection of the hand1 guide RNA and Cas9 protein ........................ 44 
2.11 T7E1 assay to determine efficiency of CRISPR/Cas9 ................................ 44-47 
2.12 Imaging and statistical analysis .................................................................. 48-51 
Chapter 3: Results 
3.1 Altering Shh signalling caused a disruption in the dorsoventral  
patterning of the developing pharyngeal region .......................................... 52-61 
3.2 Shh signalling regulated the expression of the pax1 in the 5th pharyngeal 
 arch..................................................................................................................... 62-63 
3.3 Inhibiting Bmp4 signalling resulted in an abnormal dorsoventral 
patterning of the developing pharyngeal region .......................................... 64-71 
3.4 hand1 played an active role in dorsoventral patterning of the developing  
pharyngeal region ........................................................................................ 72-78 
viii 
 
Chapter 4: Discussion 
4.1 Shh signalling regulates the dorsoventral patterning of the developing 
pharyngeal region ........................................................................................ 79-82 
4.2 Bmp4 signalling regulates the dorsoventral patterning of the developing 
pharyngeal region ........................................................................................ 82-83 
4.3 Shh signalling is required for pax1 expression in the 5th pharyngeal arch ... 83-84 
4.4 hand1 gene regulates the dorsoventral patterning of the developing 
Pharyngeal region downstream of Shh and Bmp4 signalling ...................... 85-86 
4.5 Future investigations of signalling pathways which regulate craniofacial 
morphogenesis and patterning ..................................................................... 87-89 
4.6 Conclusions ................................................................................................... 89 
Appendix – Early X. laevis embryogenesis and supplementary figures ...................... 90-100 
References…………………………………………………………………………...101-111 
Curriculum vitae…………………………………………………………………….112-114  
ix 
 
List of Tables 
                                                                                                                                    Page 
Table 1.          List of the antisense RNA probes used for marking the ventral, 
intermediate and dorsal regions of the pharyngeal complex. ............. 37 
Table 2. The sgRNA template synthesis PCR cycling conditions. .................. 41 
Table 3. Primer sequences for the synthesis of sgRNA. .................................. 42 
Table 4. T7 endonuclease assay primer sequences targeting the area  
 around the hand1gene on the short and long chromosome................ 46 
Table 5. PCR cycling conditions for amplifying the area of the  
 hand1 gene surrounding the sgRNA target sites................................ 47 
 
 
 
  
x 
 
List of Figures 
                                                                                                                                    Page 
Figure 1.         Diagrams displaying where the pharyngeal arches are located in 
X. laevis and the organization of the germ layers and neural crest 
cells within the pharyngeal region. .................................................... 6 
Figure 2.         Diagrams displaying the localization of expression of Shh and 
Bmp4 in the head region of X. laevis. ................................................ 9 
Figure 3.         Diagrams demonstrating the expression localization of Shh and 
Bmp4 in the neural tube. .................................................................... 13 
Figure 4.         Shh signalling pathway....................................................................... 17 
Figure 5.         Bmp4 signalling pathway. .................................................................. 19 
Figure 6.         Diagram displaying the expression domains of the markers of  
 ventral, intermediate and dorsal regions of the developing  
 pharyngeal complex ........................................................................... 24 
Figure 7. Diagram depicting how CRISPR/Cas9 genome editing technology 
introduces insertion or deletion into gene of interest ......................... 27 
Figure 8.         Diagram depicting the prediction of the change in the mRNA  
 localization when inducing Shh signalling by exposing  
 the X. laevis embryos to purmorphamine. .......................................... 30 
Figure 9.         Diagram depicting the predictions of the change in the mRNA  
 localization following cyclopamine inhibition of Shh. ...................... 31 
Figure 10.         Diagram depicting the predictions of the change in the mRNA  
 localization when inhibiting Bmp4 signalling by exposing 
  the X. laevis embryos to dorsomorphin and DMH1. ......................... 32 
xi 
 
 
Figure 11.       Diagram depicting the predictions of the change in the mRNA 
 localization after hand1 mutation by CRISP/Cas9 technology. ......... 33 
Figure 12. Diagram showing the location of the forward and reverse 
primers as well as the gRNA PAM sites ............................................ 43 
Figure 13. Images of X. laevis embryos displaying the markers to determine 
the effect of the reagents and mutation of the hand1 gene. ................ 50-51 
Figure 14. Inhibiting Shh signalling resulted in a dorsal shift of hand1 
expression within the developing pharyngeal region. ........................ 53-54 
Figure 15. Inhibiting Shh signalling resulted in a dorsal shift in the 
expression domain of the intermediate marker, gcm2 but not 
pax1, within the developing pharyngeal region. ................................ 56-57 
Figure 16. Pharmacological activation of Shh signalling caused a ventral 
shift in the expression of the dorsal marker, pou3f3, in the 
developing pharyngeal region. ........................................................... 59-61 
Figure 17. Inhibiting Shh signalling resulted in the loss of expression of pax1 
in the 5th pharyngeal arch. .................................................................. 63 
Figure 18. Inhibiting Bmp4 signalling resulted in a ventral shift of the hand1 
expression domain. ............................................................................. 65 
Figure 19. Inhibiting Bmp4 signalling resulted in a ventral shift of the gcm2 
and pax1 expression domain in the developing pharyngeal region. .. 67-68 
Figure 20. Inhibiting Bmp4 signalling resulted in a ventral shift of the dorsal 
marker, hoxa3. .................................................................................... 70-71 
Figure 21. T7E1 assay results demonstrating that CRISPR/Cas9 genome 
editing was successful at causing mutations in the hand1 gene. ........ 73 
xii 
 
Figure 22. Embryos that had hand1 mutated using CRISPR/Cas9 showed a 
dorsal shift in the expression domain of gcm2 but not pax1. ............. 75-76 
Figure 23. Mutations in hand1 resulted in no change of the dorsal marker, 
prrx2, expression domain within the developing pharyngeal 
region .................................................................................................. 78 
Supp. Fig. 1.   Images demonstrating that inhibiting Shh signalling resulted in a 
dorsal shift of hand1 expression within the pharyngeal region. ........ 91 
Supp. Fig. 2. Images showing inhibition of Shh signalling resulted in a dorsal 
shift in the expression domain of the intermediate marker gcm2 
within the developing pharyngeal region. .......................................... 92 
Supp. Fig. 3.  Images demonstrating inhibiting Shh signalling resulted in a 
dorsal shift of pou3f3 expression within the developing 
pharyngeal region. .............................................................................. 93 
Supp. Fig. 4.  Images demonstrating that inhibiting Bmp4 signalling resulted in 
a ventral shift of hand1 expression within the pharyngeal region. .... 94 
Supp. Fig. 5. Images showing that inhibiting Bmp4 signalling resulted in a 
ventral shift of gcm2 expression within the pharyngeal region. ........ 95 
Supp. Fig. 6. Images demonstrating that inhibiting Bmp4 signalling resulted in 
a ventral shift of pax1 expression within the pharyngeal region. ....... 96 
Supp. Fig. 7.  Images demonstrating that inhibiting Bmp4 signalling resulted in 
a ventral shift of hoxa3 expression within the pharyngeal region. ..... 97 
Supp. Fig. 8. Images of embryos that had hand1 mutated using CRISPR/Cas9 
showed a dorsal shift in the expression domain of gcm2. .................. 98 
Supp. Fig. 9. Mutations in hand1 resulted in a trending dorsal shift of the hoxa3 
expression domain .............................................................................. 99-100 
 
 
xiii 
 
List of Abbreviations 
µg – Micrograms 
µL – Microlitres 
µM – Micromolar 
bHLH – basic helix-loop-helix 
Bmp4 – Bone morphogenetic factor 4 
cDNA – complementary deoxyribonucleic acid 
CRISPR/Cas9 – clustered regularly interspaced short palindromic repeats/ 
caspase 9 
CY – cyclopamine 
dH2O – distilled water  
DIG – digoxigenin 
DMH1 – dorsomorphin homolog 1 
DMSO – dimethyl sulfide 
DNA - deoxyribonucleic acid 
RNA - ribonucleic acid 
EtOH – ethanol 
g - grams 
gcm2 – Glial Cells Missing Homolog 2 
h - hour 
hand1 – Heart and Neural Crest Derivatives Expressed 1 
hoxa3 – Homeobox A3 
L - litres 
xiv 
 
M – molar 
mg - milligram 
mL - millilitre 
mM – millimolar 
mn - minute 
mRNA – messenger ribonucleic acid 
ºC – Degrees Celsius 
pax1 – Paired Box 1 
PCR – polymerase chain reaction 
PMA – purmorphamine 
prrx2 – Paired Related Homeobox 2 
RA – retinoic acid 
rpm – revolutions per minute 
sgDNA – single guide deoxyribonucleic acid 
Shh – Sonic Hedgehog 
T7E1 – T7 endonuclease 1 
TGF-β - Transforming growth factor beta 1 
UV – ultraviolet  
Wnt - Wingless-related integration site 
X. laevis – Xenopus laevis 
  
1 
 
 
Chapter 1: Introduction 
      Craniofacial morphogenesis is a complex developmental process that requires the 
precise orchestration of many molecular and morphogenetic events (Ataliotis et al., 2005; 
Ferguson and Graham, 2004; Graham and Smith, 2001; Ho et al., 1994; Noden and 
Trainor, 2005; Rinon et al., 2007).  Structures such as the muscles of mastication, nerves 
needed for facial expression and the thyroid and parathyroid glands are a few of the 
important adult structures of the head and neck region that require proper early 
embryonic development of the pharyngeal region (Frisdal and Trainor, 2014).  Since 
many adult structures and features of the head and neck region originate from the 
developing pharyngeal region, this area has been the focus of many studies to understand 
how patterning occurs and potential developmental origins of disorders and diseases 
(Escriva et al., 2002; Jones and Trainor, 2004; Scambler, 2000; Stewart et al., 2013).  The 
purpose of this thesis is to advance the knowledge of how the pharyngeal region develops 
and to determine the factors that are regulating the dorsoventral patterning of the 
developing pharyngeal complex. 
1.1 Xenopus laevis as a model for development 
     The South African clawed frog, Xenopus laevis, is a well-characterized model of 
development that has been used extensively over the past century to investigate many 
aspects of early embryogenesis.  Some of the numerous advantages it has for studying early 
development include that many early developmental signalling pathways, morphological 
processes, and genes are all conserved between X. laevis and mammalian development.  
These conserved characteristics make Xenopus an appropriate model of development when 
investigating developmental events and diseases that occur in humans (Dickinson, 2016; 
Haremaki et al., 2015; Nie and Bronner, 2015).   
     One of the significant advantages of using X. laevis as a model of development is the 
ability of the embryos to tolerate extensive manipulation.  Embryos can be exposed to 
reagents, have essential tissue extirpated, or DNA, mRNA or proteins can be injected to 
test specific hypotheses about the roles of signalling pathways or specific genes during 
early embryonic development (Blum and Ott, 2018; Tandon et al., 2017; Wheeler and 
Brändli, 2009).  Exposure to reagents is easily performed because embryonic development 
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occurs externally in very simple culture conditions.  Xenopus embryos can be treated 
directly by adding the reagents to the media in which the embryos are developing. (Gordon 
et al., 2010; Tabler et al., 2014).   
     Pertinent to this thesis is that the conserved biological characteristics of Xenopus also 
enables the use of CRISPR/Cas9 genome editing technology.  The ability to rapidly inject 
large numbers of embryos with CRISPR/Cas9 reagents allows one to generate large 
numbers of embryos with mutations in specific genes that are required in conserved 
developmental events (Bhattacharya et al., 2015; Tandon et al., 2017). 
     X. laevis also has a well-documented fate map of the early blastomeres allowing for 
physical or chemical manipulation of specific embryonic regions (Dale and Slack, 1987).  
The ease of manipulation coupled with the well-defined fate map allows for the 
investigation into the exact developmental stages when specific tissues or signalling 
pathways are required.  Xenopus embryos all develop at the same rate that is strictly 
dependent on temperature and this allows one to manipulate the rate of development by 
simply changing temperature.  Lastly, perhaps the most beneficial property of Xenopus as 
a model of development is that the females can produce hundreds of eggs which 
synchronously develop once fertilized.  This is advantageous to studies comparing 
experimental and control embryos, often using whole-mount in situ hybridization to study 
the localization of RNA, because large cohorts of embryos can be easily obtained.  This 
allows for hundreds of observations and hence a large N-value when statistically analyzing 
those images.   
     One of the few complexities of using X. laevis as a model system is that these frogs are 
tetraploid.  Specifically, X. laevis is an allelotetraploid species because it is a result of a 
hybridization event between two parental species. Two diploid progenitors, one closely 
related to Xenopus tropicalis and another ancient diploid Xenopus are the sources of the 
two diploid sets of chromosomes.  Those two progenitor species had 20 chromosomes and 
the reason that X. laevis has 38, rather than 40 chromosomes, is that chromosome 9 and 10 
have fused (Matsuda et al., 2015; Session et al., 2016).  The two sets of chromosomes are 
referred to as the long chromosome and the short chromosome and individual genes have 
“l” or “s” behind their name if both sets of genes are still present: (for example hand1l and 
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hand1s) (Session et al., 2016).  Therefore, genetic studies, specifically ones dealing with 
mutating genes, can be more complex.  For example, X. laevis has four potential targets in 
the one cell embryo for a particular gene product if using CRISPR/Cas9 gene editing.  In 
order to circumvent this complexity, multiple guide RNAs for CRISPR/Cas9 studies may 
be required to target both the long and short chromosome version of a particular gene in 
order to ensure that all gene copies are mutated (Tandon et al., 2017). 
     As mentioned earlier the vast majority of cellular pathways and developmental events 
are conserved between X. laevis and their mammalian counterparts.  Two of the signalling 
pathways that are conserved are the Sonic hedgehog (Shh) and Bone morphogenetic 
protein (Bmp) signalling pathways which regulate morphological and patterning events 
throughout X. laevis development (Briscoe et al., 1999; Liem et al., 2000; Liem Jr. et al., 
1997; Timmer et al., 2002).  Not only are signalling pathways conserved but embryonic 
structures are conserved as well.  One such structure is the developing pharyngeal region.  
In fact, segmentation and the creation of slits in the developing pharyngeal region is a 
defining characteristic of all chordates.  The pharyngeal region and its patterning are the 
focus of this thesis. 
1.2 Early embryonic development of the pharynx  
     The fully developed pharynx is located in the neck region and is situated between the 
oral and nasal cavity and the esophagus and larynx.  The pharynx is crucial to the survival 
of all vertebrates given that the pharynx facilitates respiration by connecting the nasal and 
oral cavity to the larynx, while, also connecting the oral cavity to the esophagus allowing 
for digestive functions.  One of the key reasons why the developing pharyngeal region is 
the focus of many developmental studies is that this area later gives rise to bones, cartilages, 
tissues, arteries, veins, and nerves of the head and neck region (Frisdal and Trainor, 2014).  
Pharyngeal endoderm also gives rise to the thymus, parathyroid, thyroid, and 
ultimobranchial bodies and disruptions in patterning can give rise to defects in these organs 
(Graham and Smith, 2001).  Developmental studies of the pharyngeal region are also 
important because one in three congenital disorders affects the head and neck region and 
those defects may have developmental origins starting in the pharyngeal region including 
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Pierre Robin sequence and DiGeorge syndrome (Jones and Trainor, 2004; Scambler, 2000; 
Stewart et al., 2013). 
     As mentioned earlier, the basic pharyngeal region structure is conserved across all 
vertebrates (Square et al., 2015).  This allows one to study the development of the pharynx 
and facial malformations associated with human disorders in model organisms that can be 
easily manipulated, either pharmacologically or genetically, including mice, zebrafish, and 
X. laevis (Ataliotis et al., 2005; Stewart et al., 2013).   
     During early embryonic development, the developing pharyngeal region can be 
identified as the reiterated series of outgrowths called pharyngeal arches on the lateral side 
of the embryo towards the ventral side of the developing head (Fig. 1A).  The number of 
pharyngeal arches is species-dependent and can range from four to nine.  X. laevis 
possesses seven pharyngeal arches which develop in sequential order.  The first pharyngeal 
arch first develops at stage 23 and by stage 35 (Appendix) the first five pharyngeal arches 
can be identified on the lateral sides of the embryo  (Fig. 1A).  The development of the 
pharyngeal region is complex since it requires interaction between all three germ layers 
(endoderm, mesoderm and ectoderm) along with migrating neural crest cells (Ataliotis et 
al., 2005; Ferguson and Graham, 2004; Graham and Smith, 2001; Ho et al., 1994; Noden 
and Trainor, 2005; Rinon et al., 2007).  The ectoderm surrounds the exterior of the 
pharyngeal arches which is defined as the pharyngeal cleft and groove.  The interior portion 
of the pharyngeal arches, which is referred to as the pharyngeal pouch, is laminated with 
the endoderm (Fig. 1B).  The ectoderm and endoderm come in close proximity with one 
another in the pharyngeal clefts, therefore, it is suspected that this close interaction between 
the two layers may be required for the complete perforation and opening of the pharyngeal 
gill slits in X. laevis embryos. This hypothesis is based on previous research showing that 
proximity of ectoderm and endoderm control the opening of the mouth in X. laevis embryos 
(Dickinson and Sive, 2006; Tabler et al., 2014).  In the arch region between the clefts where 
the ectoderm and endoderm are adjacent, the space found between the ectoderm and 
endoderm is made up of mesoderm and neural crest cells that have delaminated from the 
mid- and hindbrain border (Frisdal and Trainor, 2014; Graham and Smith, 2001).  Later in 
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the development of the pharyngeal region, each of the pharyngeal arches will give rise to 
specific skeletal, vascular, and muscle derivatives (Frisdal and Trainor, 2014).   
     In frogs the first pharyngeal arch will give rise to structures including but not limited to 
gill primordium, maxilla, and mandible, while the second pharyngeal arch later develops 
into the second aortic arch, upper part of the hyoid bone and stapes (Frisdal and Trainor, 
2014).  In the later stages of development the lower hyoid bone and common carotid artery 
originate from the third pharyngeal arch, whereas the thyroid and thymus derive from the 
fourth pharyngeal arch (Frisdal and Trainor, 2014).  The fifth pharyngeal arches later gives 
rise to laryngeal cartilage and muscle (Frisdal and Trainor, 2014). 
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Figure 1.  Diagrams displaying where the pharyngeal arches are located in a stage 35 
X. laevis embryos and the organization of the germ layers and neural crest cells within 
the pharyngeal region.  (A) The pharyngeal arches (purple) of a stage 35 X. laevis 
embryos can be identified by the reiterated series of outgrowths on lateral side of the head 
region of the embryo.  (B) A schematic through the transverse section of the pharyngeal 
region of X. laevis.  The exterior of the pharyngeal arches is covered by ectoderm (red), 
while, the interior of the pharyngeal arches is covered by a layer of endodermal cells 
(green). Within the pharyngeal arches the ectoderm and endoderm cover a layer of neural 
crests cells (blue) and at the centre of the group of neural crest cells is a mesodermal core 
(yellow).  
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     During development of the arches, there is a clear anteroposterior pattern to the 
developing arches as evident by the different tissues formed from pharyngeal arches 
(Escriva et al., 2002; Frisdal and Trainor, 2014).  This anteroposterior pattern is in part, 
regulated by retinoic acid (RA) signalling (Escriva et al., 2002).  In Amphioxus, addition 
of exogenous RA results in an anterior shift in the expression of AmphiTR2/4 which is 
found within the second pharyngeal arch while blocking RA signalling by exposing 
Amphioxus to BMS009, an RA inhibitor, was able to shift the expression of AmphiTR2/4 
to the posterior region of the developing pharyngeal region (Escriva et al., 2002).  
Furthermore, it has been established that the Hox genes are key elements of the 
anteroposterior pattern in the developing pharyngeal region (Hunt et al., 1991; Maconochie 
et al., 1999).  More specifically, different Hox genes are expressed in different neural crest 
cell subpopulations and the presence or absence of certain Hox genes will give neural crest 
cells positional identity. The identity of neural crest cells found in specific pouches along 
the anteroposterior axis of the developing pharyngeal region are co-linear with the Hox 
gene numbers in the region of the neural tube where the neural crest cells are derived (Hunt 
et al., 1991a, 1991b; Maconochie et al., 1999; Trainor and Krumlauf, 2000; Tümpel et al., 
2002, 2008).  If the Hox genes are misregulated, such as by silencing Hoxa3, skeletal 
elements, normally found in the first pharyngeal arch, shift into the second pharyngeal arch 
and structures such as Meckel’s cartilage, incus, and malleus which are normally found in 
the second pharyngeal arch are shifted into the first pharyngeal arch region (Gendron-
Maguire et al., 1993; Kontges and Lumsden, 1996; Rijli et al., 1993).  This anteroposterior 
patterning has been extensively studied due to the role of individual arches in forming 
specific structures such as a the thyroid, thymus and bones of the face (Frisdal and Trainor, 
2014; Minoux and Rijli, 2010). 
     Not only does the developing pharyngeal region display anteroposterior patterning but 
it also displays patterning along the dorsoventral axis (Square et al., 2015).  In order to 
understand the evolution of skeletal components derived from the arches during 
development, Square et al. (2015) demonstrated that several specific genes are 
differentially expressed along the dorsoventral axis of the developing pharyngeal region in 
Xenopus embryos (Square et al., 2015).   This dorsoventral pattern within the pharyngeal 
region has also been observed in zebrafish and mice (Jeong et al., 2008; Talbot et al., 2010).  
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In both studies, expression of genes such as hand2, dlx2/4 and pou3f3 were restricted to 
the ventral, intermediate or dorsal regions of the developing pharyngeal region (Jeong et 
al., 2008; Talbot et al., 2010).  Also dlx genes were demonstrated to play important roles 
in patterning the developing pharyngeal region and in regulating proper formation of 
skeletal structures arising from this area (Jeong et al., 2008; Talbot et al., 2010).  Although 
these studies have shown that the developing pharyngeal region displays dorsoventral 
patterning, to my knowledge the signalling molecules that are responsible for establishing 
that pattern remain unknown (Jeong et al., 2008; Square et al., 2015; Talbot et al., 2010).    
     Perhaps the best understood example of dorsoventral patterning of a structure in the 
early embryo is in the neural tube where opposing gradients of Shh and Bmp4 signalling 
are necessary to establish a pattern of neuronal identities along that axis (Briscoe et al., 
1999; Liem et al., 2000; Liem Jr. et al., 1997; Timmer et al., 2002).  Expression profiles of 
Shh and Bmp4 around the pharyngeal region suggest that they may be available to help 
generate the dorsoventral pattern in the developing pharyngeal region (Fig. 2). If so, it 
should be noted that the gradients would be inverted as compared to the neural tube (Fig. 
3) with Shh found on the dorsal side and Bmp4 found on the ventral side of the developing 
pharyngeal region (Barnett et al., 2012; Rankin et al., 2012). 
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Figure 2.  Diagrams depicting the localization of Shh and Bmp4 mRNA in the head 
and neck region of stage 35 X. laevis embryos.  (A) Shh expression (purple) is observed 
anterior to the pharyngeal region including and up to the first pharyngeal arch, and dorsal 
to the five pharyngeal arches.  (B) Bmp4 expression (blue) is observed ventral to the 
pharyngeal region.  Data is based on previous expression studies (Koide et al., 2006; 
Rankin et al., 2012).  
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1.3 Axial Patterning in the Embryo 
     The anteroposterior, dorsoventral, and left-right axes are three axes along which an 
embryo develops.  X. laevis has been extensively used to study how these three axes are 
generated and the possible consequences of their malformation due to aberrant molecular 
signalling or incorrect cellular divisions (Altaba and Melton, 1989; Campione et al., 1999; 
Suzuki et al., 1994).  In particular, the molecular mechanisms that establish the 
dorsoventral axis of the embryo is particularly well understood in Xenopus.  A microtubule-
based mechanism initiated by entry of the sperm centriole drives beta-catenin to the dorsal 
side of the just fertilized embryo causing a canonical wingless (wnt) signal that defines that 
side of the embryo as being dorsal (Weaver and Kimelman, 2004).  Later in the developing 
Xenopus embryo the neural plate forms from ectoderm on the dorsal side of the embryo.  
That plate then rolls to form the neural tube and the subsequent tube then establishes its 
own dorsoventral pattern (Christen and Slack, 1997; McMahon et al., 1998; Yost, 1990).  
     A neural tube is found in all vertebrate embryos and is the precursor to the brain and 
spinal cord, thereby making correct patterning of the neural tube crucial to the embryo’s 
survival.  One characteristic of dorsoventral patterning in the neural tube is that specific 
subtypes of neurons differentiate according to their position in the dorsoventral axis and 
this is crucial for proper motor, sensory and interneuron neuron development (Barth et al., 
1999; Basler et al., 1993; Ericson et al., 1996; McMahon et al., 1998; Nguyen et al., 2000; 
Sander et al., 2000; Vallstedt et al., 2001; Yamada et al., 1993).  
     A key element in establishing the dorsoventral axis in the neural tube is secretion of the 
Shh ligand (Ericson et al., 1996; Roelink et al., 1995).  The secretion of the Shh ligand 
from the notochord initiates the secretion of Shh in the floor plate.   The further from this 
ventral source of the ligand within the neural tube, the lower the concentration of the Shh 
ligand resulting in the formation of a Shh gradient (Ericson et al., 1996; Roelink et al., 
1995).  Concurrently, Bmp4 is secreted from the epidermis dorsal to the neural tube, 
prompting the cells found in the roof plate of the neural tube to also secrete Bmp4 (Liem 
Jr. et al., 1995, 1997).  The Bmp4 concentration is high at the dorsal pole of the neural tube 
with levels of Bmp4 decreasing ventrally along the dorsoventral axis (Liem Jr. et al., 1995, 
1997).  Thus, Shh and Bmp4 form opposing gradients along the dorsoventral axis (Fig. 3) 
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(Briscoe et al., 1999; Liem et al., 2000; Liem Jr. et al., 1997; Timmer et al., 2002).  The 
levels of signalling ligand that the cells in the neural tube receive provides cells with 
positional information along the dorsoventral axis so that they can express and/or repress 
specific transcription factors (Nguyen et al., 2000; Sander et al., 2000).  A combinatorial 
code based on the expression of these transcription factors specifies the different subtypes 
of neurons according to their position along the dorsoventral axis.  For example, sensory 
neurons differentiate near the dorsal side of the neural tube and motor neurons are clustered 
near the ventral pole of the neural tube (Briscoe et al., 1999; Ericson et al., 1995; Liem et 
al., 2000; Liem Jr. et al., 1995, 1997; Roelink et al., 1995; Timmer et al., 2002). 
     The dorsoventral patterning of the neural tube is just one case of many processes 
where proper expression of Shh and Bmp4 are required for correct embryonic 
development.  Another such developmental event that requires these signalling pathways 
is during the development of the kidneys (Nishinakamura and Sakaguchi, 2014; Yu et al., 
2002).  More specifically Shh signalling is required to promote mesenchymal cell 
proliferation, and regulates the time point at which differentiation of smooth muscle 
progenitor cells occurs in the ureteral mesenchyme (Yu et al., 2002).  Mice in which Shh 
was mutated displayed phenotypes of renal hypoplasia, hydronephrosis and hydroureter 
demonstrating the necessity of expressing Shh at the correct time points and locations 
during the development of the kidney (Yu et al., 2002).  Whereas Bmp4 is required to 
prevent ureteric bud attraction and combined with the Bmp antagonist, Gremlin, are 
required to initiate ureteric budding (Nishinakamura and Sakaguchi, 2014).  Mice in 
which Bmp4 is mutated exhibit characteristics similar to human congenital anomalies of 
the kidney and the urinary tract including hypoplastic kidneys and hydroureter 
(Nishinakamura and Sakaguchi, 2014).  A third region of the developing embryo where 
these signalling ligands displayed a similar expression profiles to the neural tube is 
around the developing pharyngeal region (Fig. 2) (Barnett et al., 2012; Rankin et al., 
2012).  The location of Shh and Bmp4 expression within the developing pharyngeal 
region is the inverse of their positioning within the neural tube with respect to the 
dorsoventral axis.  Shh is expressed dorsal to the developing pharyngeal region and 
Bmp4 is expressed ventral to the developing pharyngeal region (Fig. 2) (Barnett et al., 
2012; Rankin et al., 2012).  
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Figure 3.  Diagram demonstrating the expression localization of Shh and Bmp4 in the 
neural tube.  In the neural tube, the initial secretion of the Shh ligand (purple) originates 
from the notochord at the ventral side of the neural tube and causes cells located in the 
floor plate to also secrete the Shh ligand.  Along the dorsoventral axis, there is a gradient 
of Shh protein from a high concentration found around the ventral pole and decreasing 
levels moving towards the dorsal side of the neural tube.  A similar pattern is observed with 
the Bmp4 (blue) protein levels along the dorsoventral axis.  A higher concentration of 
Bmp4 ligand is observed at the dorsal pole and decreases moving towards the ventral pole.  
Together these signalling molecules create opposing gradients which pattern the neural 
tube along the dorsoventral axis.    
Shh 
Bmp4 
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1.4 Sonic hedgehog (Shh) signalling 
    Sonic hedgehog (Shh) is one of the three Hedgehog signalling proteins (the other two 
are Indian and Desert hedgehog) and has been implicated in many biological processes 
throughout an organism’s lifespan including events in early development, tissue 
regeneration, stem cell renewal and cancer (Bailey et al., 2008; Ericson et al., 1995; 
Machold et al., 2003).  In addition to its role in patterning the neural tube, Shh is required 
for many critical patterning events in invertebrates and vertebrates (Ericson et al., 1995; 
Laufer et al., 1994; Rankin et al., 2016). One such place that Shh plays a critical role is 
during the development of the limb (Laufer et al., 1994; Tickle and Towers, 2017).  Here 
Shh not only provides positional information for cells along the anteroposterior axis (thumb 
to little finger) but also stimulates mesenchymal cell proliferation to control the width of 
the limb and regulates the anteroposterior length of the apical ectodermal ridge which is 
important for developing the correct structures along the proximo-distal axis of the 
developing limb (Laufer et al., 1994; Tickle and Towers, 2017). With respect to Xenopus, 
Shh is expressed in defined locations during specific stages of development such as ventral 
to the neural tube, in the floor plate, in the limb bud, and dorsal to the pharyngeal region 
(Ericson et al., 1995; Koide et al., 2006; Laufer et al., 1994).   
     The Shh ligand is a protein that requires multiple modifications for the ligand to become 
a functional signalling protein.  The Shh protein precursor is initially proteolytically 
cleaved into an amino terminus (Shh-N) and a carboxy terminus (Shh-C) peptides 
(Choudhry et al., 2014).  Shh-N has been demonstrated to be the peptide which is crucial 
for Shh signalling (Choudhry et al., 2014).  Following cleavage, auto-proteolysis occurs 
which then allows for a cholesterol moiety to be added to the C-terminus of Shh-N peptide 
(Choudhry et al., 2014).  Next, Skinny hedgehog acyltransferase attaches a palmitoyl group 
on the N-terminal of Shh which is vital for regulating the secretion of Shh and the ability 
for Shh to signal at longer-ranges (Chamoun et al., 2001; Lewis et al., 2001; Liu et al., 
2016; Zeng et al., 2001).  Once it has undergone these post-translational modifications it 
can be used in intercellular signalling.   
     When there is an absence of the fully post-translationally modified Shh ligand, the co-
receptor, Smoothened, which is located at the cell surface of the target cell, is kept in an 
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inactive form by the transmembrane receptor protein, Patched, and regulating the activity 
of the downstream transcription factors Gli1, Gli2, and Gli3.  With no ligand present, Gli1 
will be phosphorylated, targeting it for degradation, and Gli2 and Gli3 will be proteolyzed 
to produce their repressor forms by the glycogen synthase kinase (GSK3), tyrosine-protein 
kinase (CSK) and protein kinase A (PKA) complex preventing upregulation of Shh target 
genes.   
     However, when the fully post-translationally modified Shh ligand is present and bound 
to Patched, Smoothened is no longer negatively regulated by Patched.  This allows 
Smoothened to locate to the cilium thereby allowing Gli1 and Gli2 to be processed into 
their activator conformations.  Therefore, the Gli1 and Gli2, in their transcriptional 
activator forms, are then able to translocate to the nucleus where they up regulate Gli-
responsive target genes by outcompeting the Gli3 repressor (Fig. 4).   
     Two of the most effective small molecular reagents that are used to either 
pharmacologically activate or inhibit the Shh signalling pathway are purmorphamine and 
cyclopamine, respectively (Chen et al., 2002; Sinha and Chen, 2006).  Purmorphamine, the 
Shh signalling activator, has been shown to activate Shh signalling by directly targeting 
the heptahelical bundle of Smoothened causing a conformational change that results in 
Smoothened remaining in its active form even in the absence of the Shh ligand (Sinha and 
Chen, 2006).  Consequently, Smoothened retains its active conformation and Gli3 
repressor is marked for degradation while, Gli1 and Gli2 are no longer marked for 
degradation allowing them to translocate to the nucleus where they upregulate Shh target 
genes leading to the pathway being constitutively active.  
     Cyclopamine is a well-established Shh signalling inhibitor (Chen et al., 2002).  
Cyclopamine inhibits the Shh signalling pathway by directly binding to the heptahelical 
bundle of the co-receptor, Smoothened, consequentially causing a conformational change 
of Smoothened (Chen et al., 2002). This conformational change results in Smoothened 
remaining in its inactive form even when the Shh ligand is bound to Patched (Chen et al., 
2002).  Since Smoothened is restricted to its inactive conformation, the Gli1 activators are 
phosphorylated, priming them for degradation, while, Gli2 and Gli3 transcription factors 
are modified to become repressors.  As repressors, Gli2 and Gli3 translocate to the nucleus 
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where the transcription factors repress Shh target genes leading to the inhibition of the Shh 
signalling pathway. 
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Figure 4. The Shh signalling pathway.  The Shh signalling pathway is initiated when 
the Shh ligand binds to the transmembrane receptor, Patched.  As a result of this 
interaction, Patched which is localized near the base of the cilium exits and Smoothened 
now migrates into the cilium.  Since Smoothened is now present in the cilium, 
Smoothened’s activity is no longer inhibited and it can now prevent the Gli proteins from 
being degraded or converted into repressors by the GSK3, CSK and PKA complex.  
Therefore, the Gli proteins can act as activators and then translocate to the nucleus where 
they upregulate Gli-responsive target genes.  Purmorphamine is a small molecule 
activator of the Shh signalling pathway which results in the constrictive upregulation of 
Shh target genes.  Conversely, cyclopamine is used as a small molecule inhibitor of the 
Shh signalling pathway and when administered it causes inhibition of the Shh signalling 
pathway even in the presence of the Shh ligand. 
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1.5 Bmp4 signalling 
    Bone morphogenetic proteins (Bmps) are a group of signalling molecules that are a part 
of the Transforming Growth Factor-β (TGF- β) superfamily of secreted proteins. Bone 
morphogenetic protein 4 (Bmp4) is highly conserved among vertebrates and plays crucial 
roles in embryogenesis and maintenance of adult tissue homeostasis (Bei and Maas, 1998; 
Qian et al., 2013; Timmer et al., 2002). Bmp4 is particularly well known for its role as the 
dorsal signal during the dorsoventral patterning of the neural tube in vertebrates (Timmer 
et al., 2002). Bmp4 also regulates dorsoventral patterning of somite derivatives and 
anteroposterior patterning of the limbs (Beck et al., 2001; Drossopoulou et al., 2000; 
Schmidt et al., 1995).   
     Bmp4 signalling is first initiated when the Bmp4 ligand binds to the Bmp type I 
receptors ALK2, ALK3, and ALK6 and type II serine/threonine kinase heterodimeric 
receptors causing the type II receptor to transphosphorylate the type I receptor.  This in 
turn leads to the phosphorylation of the receptor-regulated Smad 1/5/8 intracellular proteins 
which then form a complex with Smad 4 protein, a common-mediator.  The Smad 1/5/8 – 
Smad 4 complex then translocates to the nucleus where the complex upregulates Bmp4 
target genes (Fig. 5).   
     Several small molecular reagents have been identified that can broadly and selectively 
inhibit the Bmp pathways.  One common broad inhibitor of the Bmp pathways is 
dorsomorphin although it is also known to inhibit 5' AMP-activated protein kinase 
signalling (Gao et al., 2008; Yu et al., 2008).  A more commonly used specific inhibitor of 
the Bmp4 pathway is Dorsomorphin Homolog 1 (DMH1) (Hao et al., 2010, 2014).  
Dorsomorphin blocks the Bmp signalling pathway by preventing phosphorylation of the 
BMP type I receptors by the Bmp type II receptor while DHM1 inhibits the Bmp4 
signalling pathway by binding to the intracellular kinase domain of the Bmp type I receptor 
(Hao et al., 2010, 2014; Yu et al., 2008).  Therefore, following treatment with 
Dorsomorphin or DMH1, Smad 1/5/8 proteins are no longer able to be phosphorylated and 
thus cannot form a complex with Smad 4 protein in order to translocate to the nucleus to 
upregulate Bmp target genes.   
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Figure 5. Bmp4 signalling pathway.  The Bmp4 signalling pathway is initiated when a 
Bmp4 ligand binds to the Bmp type I and II heterodimeric receptors resulting in the 
phosphorylation of the Bmp type I receptor.  This phosphorylation event leads to the 
phosphorylation of Smad 1/5/8 which then is able to form a complex with a Smad 4 protein.  
This Smad complex then translocates to the nucleus where it upregulates Bmp4 target 
genes.  Two small molecular reagents that are used to inhibit the Bmp signalling pathway 
are dorsomorphin and DMH1.   
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1.6 Regional dorsoventral pattern within the developing pharyngeal complex 
     In order to understand dorsoventral patterning, I have examined the expression of genes 
that have regional expression within the developing pharyngeal complex.  I have roughly 
divided the expression domains into three regions based on their expression along the 
dorsoventral axis: ventral, intermediate and dorsal expression domains.  The expression 
domains are visualized using whole-mount in situ hybridization.  All of the genes used as 
regional markers encode transcription factors that are critical in the development of 
structures originating from the pharyngeal region such as the thyroid, bones of the ear, and 
cartilage of the head and pharynx (Berge et al., 1998; Firulli et al., 2014; Günther et al., 
2000; Jeong et al., 2008; Liu et al., 2007; Manley and Capecchi, 1998; Su et al., 2001). 
1.6.1 Ventral pharyngeal region marker 
     The transcription factor whose expression profile was chosen as the ventral developing 
pharyngeal marker was hand1.  Expression of hand1 is initiated following gastrulation at 
the end of stage 12 (Session et al., 2016).  Following stage 12, hand1 is expressed in the 
cardiac progenitor cells, lateral plate mesoderm, and the developing pharyngeal region 
(Angelo et al., 2000; Deimling and Drysdale, 2009, 2011).  Specifically, with respect to 
the pharyngeal region at stage 35, hand1 is expressed in the ventral region of the developing 
pharyngeal complex between the posterior of the cement gland and the posterior of the 
developing pharyngeal complex (Fig. 6F). Along the dorsoventral axis hand1 expression 
begins at the most ventral edge of the developing pharyngeal complex and extends roughly 
1.4 µm ventrally.  The expression profile of hand1 has also been used to investigate 
whether retinoic acid (RA) signalling regulates the anteroposterior patterning of the lateral 
plate mesoderm (Deimling and Drysdale, 2009).  More specifically, hand1 expression was 
used as a marker of the anterior-middle domain of the lateral plate mesoderm (Collop et 
al., 2006; Deimling and Drysdale, 2009). 
     Hand1 is not only important as a marker of the developing ventral pharyngeal region 
but also could be a possible downstream regulator of the dorsoventral patterning of the 
developing pharyngeal region.  Hand1 is a basic helix-loop-helix transcription factor, and 
its expression was first characterized in X. laevis  as a regulator of cardiovascular 
development (Sparrow et al., 1998).  Hand1-null mouse embryos present with defects in 
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placentation and the linear heart tube fails to loop in the correct direction resulting in either 
a linear heart tube at the midline or slight looping to the right then left (Riley et al., 1998).  
If the placentation defects are rescued, the embryos still die from cardiovascular defects 
(Riley et al., 1998).  Not only is hand1 a vital transcription factor in the initial 
morphogenesis of the heart, but it also plays an essential role in ventricular myocyte 
differentiation and expression of a subset of cardiac genes (Smart et al., 2002). 
     Hand1 also plays a role in the development of other lineages including the lung and 
trachea along the anteroposterior axis of the developing embryo (Fernandez‐Teran et al., 
2003; Hoyos et al., 2016; Rankin et al., 2016). Here hand1 expression is restricted to the 
heart, pharyngeal mesenchyme, and the posterior lateral plate mesoderm, but lacking 
expression in the foregut lateral plate mesoderm region (Rankin et al., 2016).  This hand1 
expression which outlines the presumptive lung field is crucial for later development of the 
lung demonstrating one of many key roles the hand1 transcription factor plays during 
embryonic development (Rankin et al., 2016). 
     The hand1 gene is of particular interest to this study because hand1 is expressed in the 
developing ventral pharyngeal region and has been demonstrated to be necessary for proper 
morphogenesis (Firulli et al., 2014).  I found that not only is hand1 expression regulated 
by Shh and Bmp4 signalling during the dorsoventral patterning of the developing 
pharyngeal region, but I hypothesize that hand1 is itself is a regulator of the pattern. 
1.6.2 Intermediate pharyngeal region markers 
     The expression domain of the transcription factors gcm2 and pax1 were chosen as 
markers of the intermediate developing pharyngeal region.  This is the region where the 
gill slits will eventually open to the pharyngeal cavity.  Gcm2 is a master regulator of the 
parathyroid which is derived from endoderm of  the pharyngeal region (Correa et al., 2002; 
Kebebew et al., 2004).  Gcm2 has been demonstrated to be necessary for proper parathyroid 
gland development, expression of the parathyroid hormone, and proper expression prevents 
conditions like hyperparathyroidism (Correa et al., 2002; Günther et al., 2000; Liu et al., 
2007).  Detection of gcm2 mRNA begins in the oocyte and is observed until stage 12 at 
which point the expression becomes barely detectable until stages 29-30 when its 
expression returns.  The expression of gcm2 is solely restricted to the intermediate region 
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of the second, third, and fourth pharyngeal arches of the developing pharyngeal region at 
stage 35 (Lee et al., 2013) (Fig. 6D).   
     The second RNA chosen as a marker for the intermediate region of the developing 
pharyngeal complex was pax1.  The pax1 gene encodes a transcription factor that plays 
important roles during embryonic development. With respect to the developing pharyngeal 
complex, it is crucial for the proper development of the parathyroid glands and for complete 
separation of the pharyngeal pouch (Su et al., 2001).  During X. laevis development pax1 
is expressed  between stages 22 and 38 where it is constrained to the pharyngeal and the 
perinotochordal regions of the embryo  (Gray et al., 2009; Sánchez and Sánchez, 2013, 
2015). Within the developing pharyngeal region at stage 35, pax1 expression is restricted 
to the first five pharyngeal arches (Fig. 6E). 
1.6.3 Dorsal pharyngeal region markers 
     The expression domains that were used to mark the developing dorsal pharyngeal region 
were those of hoxa3, and prrx2, and pou3f3.  The hoxa3 gene encodes a transcription factor 
and is part of the A cluster of homeobox genes on chromosome 7 which are known to be 
regulators of patterning during embryonic development (Chojnowski et al., 2016; Manley 
and Capecchi, 1998).  Proper expression of hoxa3 is crucial for many craniofacial 
derivatives of the developing pharyngeal region such as cranial nerves, throat cartilage, 
thyroid and the parathyroid glands (Chojnowski et al., 2016; Manley and Capecchi, 1998).  
The expression of hoxa3 is detectable from the end of gastrulation at stage 12 and continues 
beyond stage 40 (Session et al., 2016).  Expression of hoxa3 is observed in several regions 
including the hindbrain, spinal cord, and developing pharyngeal region (McNulty et al., 
2005; Square et al., 2015).  At stage 35 when the developing pharyngeal region can be 
observed on either side of the head region of the embryo, the hoxa3 expression is restricted 
to the pharyngeal tissue which surrounds the third and fourth pharyngeal arches (Fig. 6A).   
      The transcription factor, prrx2, is crucial for proper development of select facial bones 
and if misexpressed, can lead to severe craniofacial malformations (Berge et al., 1998).  
Within the developing pharyngeal region its expression is necessary for the proper 
development of the mandibular processes, dentaries and the nasal cavity (Balic et al., 2009; 
Berge et al., 1998).  There is maternal mRNA for prrx2 in the oocyte, however, expression 
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is low and prrx2 expression does not become prominent until stage 20 and declines to low 
levels again by stage 40 (Session et al., 2016).  Throughout, these developmental stages 
prrx2 expression can be detected in the head region, mouth primordium and the developing 
pharyngeal region (Square et al., 2015).  With respect to the developing pharyngeal region 
and this study at stage 35, prrx2 expression is found just posterior to the cement gland 
extending to the posterior of the developing pharyngeal region.  Though the prrx2 
expression can be observed in the ventral and dorsal regions of the developing pharyngeal 
complex, no expression is present in the intermediate region (Fig. 6B).  The dorsal 
expression domain of prrx2 is the focus of this thesis when comparing the expression 
domain between control embryosand embryos in which signaling was altered or hand1 
expression knocked-down. 
     The last gene whose expression is used in this thesis as a marker for the dorsal region 
of the developing pharyngeal complex was pou3f3. The transcription factor, pou3f3, is a 
member of the POU domain family of genes which have been implicated in many 
development processes, however, pou3f3 expression has been specifically demonstrated to 
be crucial for proper development of pharyngeal derivatives such as squamosal bone, jugal 
bone, and if it is lost, there is failure of the stapes to detach from the styloid process (Cosse-
Etchepare et al., 2018; Jeong et al., 2008; Ryan and Rosenfeld, 1997).  In Xenopus, its 
mRNA is first detected at stage 8.  After stage 12,  pou3f3 is once again expressed until 
stage 40 where the expression returns to levels similar to those at stage 8 (Session et al., 
2016).  Throughout stages 12 to 40 pou3f3 expression is mainly localized to the anterior 
region of the embryo including the anterior neural fold, fore- and hindbrain, and the 
developing pharyngeal region (Cosse-Etchepare et al., 2018; Square et al., 2015).  
Expression of pou3f3 in that area of the developing embryo is localized to the dorsal region 
of the first, and second pharyngeal arches at stage 35 (Fig. 6C) (Square et al., 2015). 
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Figure 6.  Diagram displaying the expression domains of the markers of ventral, 
intermediate and dorsal regions of the developing pharyngeal complex.  The mRNA 
expression profiles used as markers for the dorsal region of the developing pharyngeal 
complex were hoxa3 (A), prrx2 (B), and pou3f3 (C).  The mRNA expression profiles 
used as markers for the intermediate region were gcm2 (D), and pax1 (E).  The mRNA 
expression profile used as a marker for the ventral region was hand1 (F). 
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1.7 CRISPR/Cas9 Genome Editing 
     Over the past ten years one approach to modifying the genome that has gained 
tremendous popularity is CRISPR/Cas9 genome editing technology.  Instead of using 
morpholinos to knock-down gene expression, many laboratories are now using 
CRISPR/Cas9 to cause mutations in genes which in turn result in the knocking-down of 
their expression (Tandon et al., 2017).  The two key molecules that cause the mutations in 
the gene of interest are the Cas9 enzyme, and a portion of RNA called the guide RNA 
(gRNA).  The enzyme and gRNA work together as a complex inside the cell’s nucleus 
where the complex searches along the DNA for small sequences called protospacer 
adjacent motifs (PAM) sites (Pickar-Oliver and Gersbach, 2019).  These PAM sites allow 
the Cas-9 enzyme to grip the DNA resulting in its destabilization leading to the unzipping 
of the double-stranded helix  (Pickar-Oliver and Gersbach, 2019).  Following, the 
opening of the DNA, the gRNA moves along the DNA searching for the complementary 
sequence (Pickar-Oliver and Gersbach, 2019).  Once the complementary sequence is 
found the gRNA activates the Cas-9 enzyme which in turn cleaves the DNA into two 
separate pieces (Pickar-Oliver and Gersbach, 2019).  The double-stranded break is 
repaired by non-homologous end-joining which is an error-prone repair mechanism that 
introduces insertions or deletions at the site of the break (Pickar-Oliver and Gersbach, 
2019).  One of the possible outcomes of the insertions or deletions is a frameshift 
mutation leading to a premature stop codon resulting in a non-functional gene (Pickar-
Oliver and Gersbach, 2019).   
     Using CRISPR-Cas9 genome editing technology in the model system, X. laevis offers 
a few more challenges than to researchers working with other models of development 
such as mice or human cells.  This is because X. laevis are tetraploid meaning that they 
carry two complete genomes.  The two sets can be differentiated based on small 
differences in chromosome size and so one set has been designated long and the other 
short (Session et al., 2016).  Although there has been some evolutionary loss of one copy 
of many genes, for the majority of the genes there are essentially four functional copies 
(Session et al., 2016).  Therefore, when attempting to knock-down genes in X. laevis 
multiple gRNAs may have to be injected in order to target both the long and short genes 
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(Yang et al., 2013).  Nevertheless, CRISPR/Cas9 technology is able to efficiently mutate 
both sets of genes without any clear toxic effects (Bhattacharya et al., 2015; Blitz et al., 
2013; DeLay et al., 2018).  CRISPR/Cas9 genome editing will be the method used to 
mutate hand1 to test the hypothesis that the hand1 gene regulates the dorsoventral pattern 
of the developing pharyngeal region downstream of Shh and Bmp4 signalling.   
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Figure 7.  Diagram depicting how CRISPR/Cas9 genome editing technology 
introduces an insertion or deletion into the gene of interest.  The enzyme and gRNA 
work together as a complex searching along the DNA for small sequences called 
protospacer adjacent motifs (PAM) sites.  These PAM sites allow the Cas9 enzyme to 
grip the DNA resulting in its destabilization leading to the unzipping of the double-
stranded helix.  The gRNA then searches for the complementary sequence.  Once the 
complementary sequence is found the gRNA activates the Cas9 enzyme which in turn 
creates a double stranded break.  The break is repaired by non-homologous end-joining 
which is an error-prone repair mechanism that introduces an insertion or deletion at the 
site of the break.  The insertion or deletions may cause a coding frameshift leading to the 
knock-down of the gene of interest.   
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1.8 Purpose of the research 
     The purpose of this study is to discover underlying signalling mechanisms that regulate 
the dorsoventral patterning of the developing pharyngeal region in X. laevis.  I utilized 
information from previous studies that have demonstrated clear patterns of gene expression 
along the dorsoventral axis in the developing pharyngeal region.  Based on the observation 
that Shh is located dorsal to the developing pharyngeal region, while Bmp4 is located 
ventral to the developing pharyngeal region, there is the potential for a counter gradient 
role for these molecules in the dorsoventral patterning of the pharyngeal complex, similar 
to the known patterning described for the neural tube (Barnett et al., 2012; Le Dréau and 
Martí, 2012; Rankin et al., 2012; Square et al., 2015).  Therefore, I hypothesize that the 
correct dorsoventral gene expression pattern observed in the developing pharynx is 
regulated by opposing gradients of Shh and Bmp4 signalling.  This thesis will investigate 
whether Shh and Bmp4 provide positional information to cells found along the 
dorsoventral axis so that the cells can activate and/or repress specific transcription factors 
known to be involved in craniofacial development.  Small molecule reagents were used to 
alter the signalling pathways in embryos prior to the pharyngeal patterning. I predict that 
activating Shh signalling by exposing the embryos to purmorphamine will result in a 
ventral shift of the mRNA expression profiles (Fig. 8).  In contrast, I predict that exposing 
embryos to cyclopamine, thereby inhibiting Shh signalling, will cause a dorsal shift in the 
mRNA expression domains in the three regions of the developing pharyngeal complex 
(Fig. 9).  Similarly, in purmorphamine treated embryos, I predict a ventral shift of the 
mRNA expression domains in the three regions of the developing pharyngeal complex 
when exposed to the Bmp inhibitors dorsomorphin and DMH1 (Fig. 10).  Finally, a second 
hypothesis is that hand1 regulates the dorsoventral patterning of the developing 
pharyngeal region.  This is due to the ventrally restricted localization of hand1 mRNA in 
the developing pharyngeal region and Shh signaling and the hand genes have been 
demonstrated to cooperatively regulate embryonic morphogenetic events (Firulli et al., 
2017; Rankin et al., 2016; Riley et al., 1998).  I predict that when the hand1 gene is mutated, 
the mRNA expression profiles in the intermediate and dorsal regions will be shifted 
dorsally (Fig. 11).  These findings will provide new information on how the developing 
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pharyngeal region is patterned and could be later used to predict the origin of defects in 
craniofacial development.  
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Figure 8.  Diagram depicting the prediction of the change in the mRNA localization 
when inducing Shh signalling by exposing the X. laevis embryos to purmorphamine.  
On the left side of the diagram is a X. laevis head and neck region with the light blue, purple 
and dark blue coloured areas marking the ventral, intermediate and dorsal regions of the 
developing pharyngeal complex, respectively.  The three centre images are X. laevis 
embryos stained for hand1, gcm2, and prrx2 which are markers for the ventral, 
intermediate and dorsal regions, respectively.  On the right side is a diagram predicting the 
ventral shift of the markers of the three regions when inducing Shh signalling through the 
exposure of the embryos to purmorphamine. 
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Figure 9.  Diagram depicting the predictions of the change in the mRNA localization 
following cyclopamine inhibition of Shh.  On the left side of the diagram is a X. laevis 
head and neck region with the light blue, purple and dark blue coloured areas marking the 
ventral, intermediate and dorsal regions of the developing pharyngeal complex, 
respectively.  The three centre images are X. laevis embryos stained for hand1, gcm2, and 
prrx2 which are markers for the ventral, intermediate and dorsal regions, respectively.  On 
the right side is a diagram predicting the dorsal shift of the markers of the three regions 
when inhibiting Shh signalling through the exposure of the embryos to cyclopamine. 
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Figure 10.  Diagram depicting the predictions of the change in the mRNA 
localization when inhibiting Bmp4 signalling by exposing the X. laevis embryos to 
dorsomorphin and DMH1.  On the left side of the diagram is a X. laevis head and neck 
region with the light blue, purple and dark blue coloured areas marking the ventral, 
intermediate and dorsal regions of the developing pharyngeal complex, respectively.  The 
three centre images are X. laevis embryos stained for hand1, gcm2, and prrx2 which are 
markers for the ventral, intermediate and dorsal regions, respectively.  On the right side is 
a diagram predicting the ventral shift of the markers of the three regions when inhibiting 
Bmp4 signalling through the exposure of the embryos to dorsomorphin and DMH1. 
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Figure 11.  Diagram depicting the predictions of the change in the mRNA 
localization after hand1 mutation by CRISPR/Cas9 technology.  On the left side of 
the diagram is a X. laevis head and neck region with the purple, and dark blue coloured 
areas marking the intermediate, and dorsal regions of the developing pharyngeal 
complex, respectively.  The two centre images are X. laevis embryos stained for gcm2, 
and prrx2 which are markers for the intermediate, and dorsal regions, respectively.  On 
the right side is a diagram predicting the dorsal shift of the markers of the intermediate 
and dorsal regions when mutating the hand1 gene by use of CRISPR/Cas9 genome 
editing technology. 
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Chapter 2: Materials and Methods 
2.1 Generation of X. laevis embryos  
     In order to induce ovulation, female X. laevis were injected with 800 IU of human 
chorionic gonadotrophin (Intravet) the night before eggs were to be fertilized.  Male X. 
laevis were sacrificed, and testes were removed and stored in 200% Steinberg’s solution.  
All Steinberg’s solutions were prepared from Steinberg’s stock solution A (68g NaCl, 1g 
KCl, 4.09g MgSO4-7H2O, 1.58g Ca(NO3)2-4H2O) and Steinberg’s stock solution B (11.2g 
Tris-HCl pH 7.4).  Eggs were squeezed from the females into 80% Steinberg’s solution 
and in vitro fertilization was accomplished using minced testes.  Embryos were de-jellied 
at stage 4 with 2.5% cysteine (pH 8.0) and washed several times with 20% Steinberg’s 
solution to remove excess 2.5% cysteine.  Embryos were staged according to the 
Nieuwkoop and Faber staging (Appendix) (P.D. Nieuwkoop and J. Faber, 1994).   All 
embryos were cultured in 3 mL of 20% Steinberg’s solution at 18ºC. 
2.2 Shh activator and inhibitor 
     Cyclopamine and purmorphamine (Toronto Research Chemicals) were prepared as 20 
mM and 10 mM stock solutions in 95% ethanol and DMSO, respectively, and stored at -
20ºC.  Based on research by Lewis and Krieg (2014) that determined effective 
concentrations for Xenopus embryos, I treated stage 13 embryos with 100 μM 
cyclopamine or 20 μM purmorphamine. Control embryos were treated with either 15 μL 
of 95% ethanol or 3 μL of DMSO in 3 mL of 20% Steinberg’s solution.  Embryos were 
continuously exposed to cyclopamine or purmorphamine from stage 13 until stage 35 
when they were fixed for whole-mount in situ hybridization.  The embryos were treated 
starting at stage 13 (Appendix) to avoid interfering with gastrulation and were fixed at 
stage 35 (Appendix) since this is the optimal stage to view the developing pharyngeal 
region. 
2.3 Bmp4 inhibitors 
     In order to inhibit Bmp signalling, embryos were treated with 40 μM DMH1 (Adooq 
Bioscience) (Rankin et al., 2015) or 10 μM dorsomorphin (Fisher Scientific) (Pieper et 
al., 2012; Yu et al., 2008).  DMH1 and dorsomorphin were both prepared as 40 mM stock 
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solutions in DMSO and stored at 4ºC.  The control treatments were 3 μL of DMSO in 
3mL of 20% Steinberg’s solution.  DMH1 and dorsomorphin was added to the culture 
media containing the embryos at stage 13 and continued until stage 35 when the embryos 
were fixed for whole-mount in situ hybridization. 
2.4 Embryo fixation 
     Embryos used for whole-mount in situ hybridization were fixed at stage 35 in 
MEMPFA (4% paraformaldehyde, 2 mM EGTA (ethylene glycol tetraacetic acid), 0.1 
mM MOPS (3-(N-morpholino) propanesulfonic acid), 1mM MgSO4, pH 8.0) and placed 
in a nutator (LabQuake) for two hours. After the MEMPFA fixation, embryos were 
transferred into 100% methanol at -20ºC until processing for in situ hybridization. 
2.5 Plasmid transformations to prepare probes 
      DH5α Escherichia coli bacteria were used as competent cells in the plasmid 
transformations.  For transformations, approximately 100 ng of plasmid DNA was added 
to 50 μL of competent cells, and the solution was then placed on ice for thirty minutes.  
The bacteria-DNA mixture was then placed on a 42ºC heating block for sixty seconds and 
then returned to ice for five minutes.  Following the ice treatment, 1 mL of Luria’s broth 
(LB) was added to the mixture and placed in the 37ºC shaking incubator for one hour.  The 
whole LB and competent cell-plasmid solution were plated on LB plates (5 g bacto-
tryptone, 2.5 g bacto-yeast extract, 5 g NaCl, 7.5 g bacto-agar for 500 mL) containing 
ampicillin (50 mg/mL) and incubated overnight at 37ºC.  Colonies were then picked using 
a tungsten loop tool and suspended in 5 mL of LB and 100 mg/mL ampicillin in a culture 
tube.  The mixture was then placed in the 37ºC incubator and shaken at 225 rpm overnight.  
Following the incubation, the plasmids were isolated and purified using the QIAprep® 
Spin Miniprep kit (QIAGEN) according to the manufacturer’s instructions. 
2.6 Restriction digest to prepare probes 
     The restriction digests were performed in a 1.5 ml Eppendorf tube using 10 μg of 
isolated and purified DNA, 1 μl of the appropriate restriction enzyme (Table 1), 5 μl of the 
appropriate buffer solution and brought to a total volume of 50 μl using dH2O.  The tubes 
were then placed in a 37ºC incubator for three hours.  Following the incubation, 50 μl of 
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dH2O was added to produce a total volume of 100 μl.  A 1:1 volume of phenol/chloroform 
isopropanol was added and vortexed.  The solution was then centrifuged at 14,000 rpm for 
three minutes.  The aqueous layer was removed and placed in a fresh 1.5 ml Eppendorf 
tube and purified by adding 1/10th volume of ammonium acetate (3M) and 2:1 volumes of 
100% ethanol.  The tubes were placed in the -20ºC freezer for thirty minutes and then 
centrifuged at 14,000 rpm for fifteen minutes. Following the centrifugation, the 
supernatants were removed, and the DNA pellet was air dried, washed with 70% ethanol 
and then centrifuged again at 14,000 rpm for ten minutes.  Following the centrifugation, 
the ethanol was removed, and the DNA was left to air dry.  The pellet was then resuspended 
in 15 μl of dH2O, and 1 μl was then run on a 1% gel and visualized under a UV 
transilluminator. 
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Table 1.  List of the antisense RNA probes used for marking the ventral, intermediate 
and dorsal regions of the pharyngeal complex.  Accompanying the names of the cDNA 
are the vector backbone inserted into, restriction enzymes used to digest the plasmid DNA, 
the RNA polymerase to synthesize the probe and from whom the cDNA was obtained from.  
cDNA Vector 
Restriction 
Enzyme 
RNA 
Polymerase 
Source 
Reference 
hand1 
pBluescript 
SK + 
BamHI T7 
(Sparrow et al., 
1998) 
gcm2 
pBluescript 
SK + 
NotI T7 
Unpublished 
(Kevin Fan and 
Taisaku Nogi) 
pax1 
pBluescript 
II SK(-) 
NotI T7 
Dr. Ueno 
(Sánchez and 
Sánchez, 2013) 
hoxa3 pSport6 SalI T7 
(Lee et al., 
2013) 
prrx2 pJet1.2 NotI SP6 
(Square et al., 
2015) 
pou3f3 pJet1.2 NotI SP6 
(Square et al., 
2015) 
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2.7 Probe synthesis for in situ hybridization  
     Using the linearized DNA template, RNA was transcribed and labeled with 
Digoxygenin so that whole-mount in situ hybridizations could be performed to determine 
the localization of mRNA of interest.  The antisense Digoxygenin-labeled probe synthesis 
was set up as follow: 1 – 2 μg of linearized template DNA, 4 μl of digoxygenin-labeled 
NTP mixture (2.5 mM CTP, 2.5 mM GTP, 2.5 mM ATP, 1.625 mM UTP and 0.875 mM 
Dig-11-UTP (Roche), 0.5 μl of RNase inhibitor (Invitrogen), 2 μl of transcription buffer 
(Invitrogen), 2 μl of appropriate RNA polymerase and brought to a total volume of 20 μl 
with dH2O (see Table 1 for PCR conditions).  The transcription reactions were incubated 
for two hours at 37°C followed by the addition of 1 μl of DNAse (Invitrogen) and incubated 
for another ten minutes at 37°C.  After incubation 1 μl was removed to check on 1% agarose 
gels.  To the remaining 19 μl, 80 μl of 1% SDS in TE buffer (10 mM Tris pH 8.0, 1 mL 
EDTA), 10 μl of ammonium acetate (5 M) and 220 μl of cold 100% ethanol were added.  
The mixture was then vortexed and set aside on ice until results of the RNA quality check 
were known.  The remaining RNA probes that were set aside on ice were precipitated by 
centrifuging at 14,000 rpm for fifteen minutes and allowed to dry briefly.  The RNA probes 
were then resuspended in 1 ml of RNA hybridization buffer and vortexed.  The probes 
were then briefly heated to 37ºC and vortexed again.  The probes were then transferred to 
a 15 ml polystyrene tube and brought to a total volume of 10 ml with RNA hybridization 
buffer. 
2.8 Whole-mount in situ hybridization 
     Whole-mount in situ hybridization was performed as previously described by (Deimling 
et al., 2015).  Embryos were contained in 3 ml glass vials (VWR) all steps were carried out 
on a nutator (LabQuake) and at room temperature unless noted.  Embryos stored in 100% 
methanol were rehydrated in a series of methanol washes (75%, 50%, and 25%) and then 
washed with TTW buffer (Tris buffered saline: 50 mM Tris (pH 7.4), 200 mM NaCl, 0.1% 
Tween-20) three times for ten minutes each.  Embryos were fixed in MEMPFA for 20 
minutes and subsequently washed with TTW three times for five minutes each.  Embryos 
were then washed with pre-warmed RNA hybridization buffer for ten minutes and once 
again at 65ºC for one hour.  Probe, previously heated to 65ºC, was then added to the vials 
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and incubated at 65ºC overnight.  The following day the probe(s) were removed and stored 
at -20ºC for further use and the embryos were incubated again at 65ºC for ten minutes in 
pre-warmed RNA hybridization buffer.  The embryos were then subjected to two twenty-
minute washes of 2 X SSC (from a 20 X SSC stock: 3 M NaCl, 0.3 M Na3C6H5O7, pH 7.0) 
at 37ºC followed by three one-hour washes of 0.2 X SSC at 65ºC.  Embryos were then 
submerged in blocking solution (MAB (pH 7.5) (100 mM maleic acid, 150 mM NaCl), 2% 
blocking reagent (Roche) and 20% heat-treated sheep serum) and then in a blocking 
solution containing DIG-labelled antibodies (anti-Digoxygenin-AP, Fab Fragments; 
(Roche)) and incubated at 4ºC overnight.  The next day the embryos were subjected to 
twelve thirty-minute washes of MAB.  Embryos were stained by BM Purple (Roche, 
Indianapolis, IN) overnight.  The following day the colourimetric reaction was fixed by 
dehydrating the embryos in a series of five methanol washes (25%, 50%, 75%, 100% and 
100%) for five minutes each and then rehydrating the embryos in a series of methanol 
washes (75%, 50%, 25%) once again for five minutes each.  Incubating the embryos in 
MEMPFA for thirty minutes further fixed the stain and was followed up by three five-
minute washes of 25% methanol.  The embryos were then bleached (5% formamide, 0.5 X 
SSC, 1% hydrogen peroxide) for four hours or until excess pigmentation was removed.  
After bleaching, embryos were then dehydrated in a series of five methanol washes (25%, 
50%, 75%, 100%, and 100%) and stored at -20°C until images were ready to be taken. 
2.9 Single guide RNA (sgRNA) of the hand1 gene synthesis 
      The first step of synthesizing the hand1 sgRNA was generation of template DNA 
through a PCR reaction, and the conditions are listed in Table 2.  The sgRNA primer 
sequences used and the universal reverse primer sequence are listed in Table 3.  The 
beginning of each sgRNA encodes a T7 promoter site followed by a specific target 
sequence followed by a universal reverse sequence.  The universal reverse primer 
contained a universal reverse sequence and codes for the Cas9 association site.  The hand1l 
and hand1s gene maps outlining the forward and reverse primer start sites, gRNA 
associated PAM sites and HLH domain are outlined in Figure 12.  After completion of the 
PCR, the products were purified on a QIAGEN Quickspin PCR column according to 
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manufacturers’ instructions.  The quantity of the PCR product was calculated by Nanodrop, 
and the quality was checked on a 1% agarose gel containing EtBr. 
     To generate the sgRNA for the hand1 gene, an in vitro transcription was performed at 
37ºC overnight using T7 RNA polymerase (Ambion Megascript Kit) in a total volume of 
20 μl containing 300 ng of PCR product, 2 μl each of ATP, CTP, GTP and UTP, 2 μl 10 X 
reaction buffer and 2 μl T7 RNA polymerase.  Following the incubation 1 μl of 
TurboDNase (Invitrogen) was added and incubated for another fifteen minutes.  Next, the 
sgRNA was purified using GE Illustra Sephadex G-50 NICK columns.  To prepare the 
columns for use, the columns were washed three times with 4 ml of TE Buffer (10 mM 
Tris (pH 8) 1 mM EDTA (pH 8)).  Afterwards, 80 μl of TE Buffer was added to the sgRNA 
reaction and applied to the column.  Once the column stopped dripping, the column was 
washed with 400 μl of TE buffer, and when the column stopped dripping again, the sgRNA 
was eluted by applying 400 μl of TE Buffer to the column.  The sgRNA was collected in 
an Eppendorf tube containing 1 ml of 100% EtOH and 10 μl of NH4 Acetate (Megascript 
Kit).  The mixture was then inverted several times followed by an incubation at -20ºC for 
forty-five minutes and then at -80ºC for fifteen minutes.  The tubes were then centrifuged 
in a microcentrifuge at 13,000 rpm for twenty minutes at 4ºC.  The pellet was washed with 
70% ethanol and air dried on the 55ºC heat block.  The pellet was resuspended in 20 μl of 
dH2O, followed by calculating the quantity using the spectrophotometer and the quality 
was checked by running on a 2% agarose and TAE gel containing EtBr.  Once the quantity 
was known and quality was confirmed, the sgRNA was diluted to 1500 ng/μl and 10 μl 
aliquots were stored at -20ºC.  Cas9 protein was received from PNA Bio Inc. (Thousand 
Oaks, CA) and resuspended in nuclease-free dH2O and stored in aliquots at -20ºC. 
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Table 2. The sgRNA template synthesis PCR cycling conditions. 
Temperature (°C) Time (seconds) Number of Cycles 
98 30 1 
98 10 
10 
62 20 
72 20 
98 10 
25 
72 30 
72 300 1 
4 Hold 1 
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Table 3.  Primer sequences for the synthesis of sgRNA.  The beginning of each sgRNA 
matches to the T7 promoter site, the nucleotides underlined are the specific target 
sequences corresponding to a region of the hand1 gene and the bolded nucleotides are 
universal primer sequences which anneal to both the target primers and the Cas9 
association site located on the universal reverse primer.  The remaining nucleotides (Bold) 
on the universal reverse primer are the Cas9 association site. 
Primer Name Sequence 
sgT1 CAGCTAATACGACTCACTATAGGAAGTAAGGTCTCTCCTGG GTTTTAGAGCTAGAAATAG 
sgT2 CAGCTAATACGACTCACTATAAGGGATCAGGCATCATGTCC GTTTTAGAGCTAGAAATAG 
sgT3 CAGCTAATACGACTCACTATAAGGATGGGTGCTCAACCCTG GTTTTAGAGCTAGAAATAG 
Universal 
Reverse Primer 
CAAAATCTGATCTTTATCGTTCAATTTTATTCCGATCAGGC 
AATAGTTGAACTTTTTCACCGTGGCTCAGCCACGAAAA 
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Figure 12.  Diagram showing the location of the forward and reverse primers as well 
as the gRNA PAM sites.  (A) Diagram of hand1l gene map demonstrating the locations 
of the forward and reverse primers, the start codon, the sgT1 PAM site and the sgT2 
PAM site.  (B) Diagram of hand1s gene map demonstrating the locations of the forward 
and reverse primers, the start codon, the sgT1 PAM site and the sgT3 PAM site.  The 
maps were created by Victoria Deveau and permission was granted to use in this thesis.  
HLH – Helix-Loop-Helix.  
A 
B 
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2.10 Microinjection of the hand1 guide RNA and Cas9 protein 
     Embryos for injection were de-jellied 20 minutes post-fertilization and transferred to 
Petri dishes containing 3% Ficoll (GE Life Sciences) in 1 X MMR solution (1 mM MgSO4, 
2 mM CaCl2, 5 mM Hepes (pH 7.8), 0.1 mM NaCl, 0.1 mM EDTA (pH 8.0), 2 mM KCl).  
Following incubation at 14ºC for 15 minutes the embryos were microinjected at the one-
cell stage using a Nanoject 3 Microinjector (Drummond Scientific Company; Broomall, 
PA).  Each embryo was injected with 1.5 ng of Cas9 protein and 750 pg of each of the 3 
sgRNA in a total volume of 7 nl.  The sgRNA was heated to 70ºC for two minutes before 
being added to the injection stock solution.  To control for microinjection of the hand1 
guide RNA and Cas9 protein embryos were injected with dH2O.  Un-injected embryos 
from the same batch were also allowed to develop until stage 35 so that whole-mount in 
situ hybridization could be performed to control for any abnormal effects caused by the 
injections process. 
2.11 T7E1 assay to determine efficiency of CRISPR/Cas9 
     DNA was extracted from five non-injected embryos, five dH2O-injected embryos and 
ten hand1 injected embryos and were placed into individual 1.5 mL Eppendorf tubes. The 
embryos were then homogenized at 55ºC overnight in 0.5 mL of homogenization buffer 
(1% SDS, 10 mM EDTA, 20 mM Tris (pH 7.5) and 100 mM NaCl), and 2.5 μL of 
proteinase K (20mg/mL).  The DNA was then extracted with 1 volume of aqueous phenol, 
followed by extracting with 1:1 mix of phenol:chloroform and once with chloroform.  
Following the extractions, the DNA was precipitated by adding 1/10 volume of 5 M 
ammonium acetate and 0.6 volumes of isopropanol.  The solution was then placed on ice 
for thirty minutes.  The precipitate was recovered by centrifuging at 12,000g for five 
minutes.  The pellet was washed with 70% ethanol and resuspended in 100 μL of TE buffer 
and treated with 10 μg/mL of RNase A and incubated at room temperature for thirty 
minutes.  The DNA was then precipitated by adding 1/10 volume of 5 M ammonium acetate 
and 0.6 volumes of isopropanol.  The precipitate was then centrifuged at 12,000g for 5 
minutes, and the pellet was resuspended in 20 μL of TE Buffer (10 mM Tris-HCl (pH 8), 
1 mM EDTA). 
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     PCR reactions were performed using the extracted DNA to amplify 750 bp of the hand1 
gene surrounding the sgRNA target sites.  The first of the two sets of primers were used so 
that both hand1l and hand1s could be examined.  Primers and the PCR conditions are listed 
in Table 4 and Table 5, respectively.  Following the PCR, 20 μl was run on a 1% agarose 
and TAE gel containing EtBr so that a single product was amplified.  The remaining 20 μl 
of PCR product was denatured at 95°C for three minutes, and then the temperature was 
dropped 1°C every sixty seconds until 4°C was reached.  Next 0.3 U of T7 endonuclease I 
(NEB) and NEB Buffer 2 was transferred to the remaining 20 μl of PCR product and 
incubated for one hour at 37ºC.  Following the digest, 15 μl of the product was run on a 
2% agarose gel containing EtBr and analyzed on the UV transilluminator.  Three bands 
appear in a lane on the gel when a mismatch of DNA was present indicating that the Cas9 
has altered the DNA at the predicted target site. 
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Table 4. T7 endonuclease assay primer sequences targeting the area around the hand1 gene 
on the short and long chromosomes. 
Primer 
Name 
Sequence 
hand1.S 
Fwd GCAGCACAGACTGAACCTGG 
Rvs CCAATTTGAGCGATTTCTACTCAC 
hand1.L 
Fwd TGCAGTGTAAGACTTTGCCTGGA 
Rvs CCTATATTCATACAACCCTACTC 
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Table 5. PCR cycling conditions for amplifying the area of the hand1 gene surrounding 
the sgRNA target sites. 
Temperature (°C) Time (seconds) Number of Cycles 
95 30 1 
95 60 
40 
55 (hand1.S) 
Or 
59 (hand1.L) 
30 
72 30 
4 Hold 1 
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2.12 Imaging and statistical analysis 
     To prepare for imaging, embryos were first rehydrated in a series of methanol washes 
(75%, 50%, and 25%) and placed in 1 X PBS and imaged on a 1% agarose plate.  Following 
rehydration, the embryos were imaged using the Leica M205 FA microscope and the 
accompanying program Leica Application Suite (version 4.4.0).  Before placing markers on 
the morphological land marks and expression domain limits, the images were assigned 
random numbers.  This was done so that I was unaware of the treatment administered to the 
embryos when assessing images in order to prevent observer bias. 
     In all of the images, lines that act as markers were placed along the embryo to perform 
quantitative analysis so that the change of RNA localization along the dorsoventral axis of 
the developing pharyngeal region could be assessed.  One of those lines was placed at the 
bottom of the cardiac cavity to act as a reference point from which all distances were 
calculated (Fig. 13).  This bottom reference line placed at the bottom of the cardiac cavity 
was orientated so that it was always parallel with the top and bottom of the staining limits.  
A third line was placed at the top of the head of each embryo from which the total distance 
of the head and neck region was calculated from the bottom reference line (Fig. 13).  This 
total distance of the head and neck region was used to create ratios to normalize the head 
and neck regions between embryos (Fig. 13).   
     For the ventral developing pharyngeal region that expresses hand1, a line was also placed 
at the top of the staining region and the distance from the bottom reference line to the top of 
the staining was determined (Fig. 13A).  A ratio was then created using this distance and 
the distance between the bottom reference line and the line at the top of the head.  This 
represented the entire head and neck region and was used to compare between treatment 
groups to determine if RNA localization shifted along the dorsoventral axis of the 
developing pharyngeal region (Fig. 13A).   
     For the genes with expression profiles that are found within the intermediate pharyngeal 
region, the marker at the bottom of the cardiac cavity was used as a reference point.  From 
which distances to the lower and upper limit of the staining were taken to calculate the 
distance from the bottom of the cardiac cavity to the centre of the staining (Fig. 13B).  The 
distances from the bottom reference line to the middle of the staining was then converted 
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into a ratio of the entire head and neck region using the distance between the reference line 
and the line at the top of the head (Fig. 13B).  This ratio was used to assess if the small 
molecular activator and inhibitors had an effect on the patterning of the genes within the 
developing pharyngeal region.   
     With respect to the dorsal region, a line was placed at the top of the staining limit of 
hoxa3 and pou3f3, while, a line was placed at the bottom of the staining limit when 
examining the prrx2 expression domains (Fig. 13C & D).  Similar to the ventral, and 
intermediate regions, the distances to these lines were converted into a ratio of the entire 
head and neck region.  This was accomplished by using the distance between the bottom 
reference line and the line at the top of the head to assess whether shifts of the expression 
domains had occurred when Shh and Bmp4 signalling was altered or following the mutation 
of the hand1 gene (Fig. 13C & D). 
     Statistical analysis was performed using Microsoft Excel (2013) and IBM SPSS 
statistical analysis package (IBM SPSS Statistics 25 2017).  Following the data collection, 
a two-sample t-test assuming equal variances was performed to compare control and 
treatment groups from which Shh signalling was altered.  One-way ANOVA test compared 
the phenotypes between different treatment groups resulting from disrupted Bmp4 
signalling and hand1 gene mutations.  This analysis was followed by a Tukey’s test to 
determine the differences between the spatial area of staining patterns observed in the 
control and experimental treatment groups. 
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Figure 13.  Images of X. laevis embryos displaying the markers to determine the effect 
of the reagents and mutation of the hand1 gene.  A lateral view of a X. laevis stage 35 
embryo stained with hand1 RNA probe (ventral marker) (A), gcm2 RNA probe 
(intermediate marker) (B), prrx2 RNA probe (dorsal marker) (C) and pou3f3 RNA probe 
(dorsal marker) (D).  For all RNA probes, a reference line was placed at the bottom of the 
developing cardiac cavity (green) (a), and the top of the head of the embryo (e) to normalize 
measurements across all embryos.  A parallel line (b) was placed at the lower limit of the 
staining for the intermediate (B) and dorsal markers (C).  An additional parallel line (d) 
was placed at the upper limit of the staining for the ventral (A), intermediate markers (B) 
and dorsal marker (D).  For the intermediate markers (B) the distance between the lower 
(b) and the upper limit (c) of the staining were subtracted to calculate the distance from the 
bottom of the cardiac cavity (green) to the middle of the staining (d). For the ventral (A) 
and dorsal (D) markers the distance between the reference line and upper limit (c) of the 
staining was determined.  For the dorsal (C) marker the distance between the reference line 
and the lower limit (b) of the staining was calculated.  The distances were then converted 
into ratios of the developing pharyngeal region (a-e) which were then used to analyze the 
effects of the small molecular reagents and mutating the hand1 gene on the dorsoventral 
patterning of the developing pharyngeal region.  
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Chapter 3: Results 
3.1 Altering Shh signalling caused a disruption in the dorsoventral patterning of the 
developing pharyngeal region 
     To test whether Shh plays a role in patterning gene expression within the developing 
pharyngeal region, the pathway was manipulated in X. laevis embryos by 
pharmacologically activating or inhibiting Smoothened, a key transducer of Shh pathway.  
Following activation or inhibition of Shh signalling, genes that have expression localized 
to the three regions of the developing pharyngeal complex were used to assess whether a 
shift occurred in their pattern of expression along the dorsoventral axis (Jeong et al., 2008; 
Square et al., 2015; Talbot et al., 2010). 
     The ventral pharyngeal marker, hand1, expression can also be observed in the heart, 
and lateral plate mesoderm, but for this thesis its broad staining patterning across the 
ventral pharyngeal region was the focus (Fig. 14A, B & D) (Deimling and Drysdale, 2009; 
Rankin et al., 2012).  Embryos were treated with either purmorphamine, a Shh activator, 
or cyclopamine, a Shh inhibitor, or treated with the vehicle controls (3µL of DMSO and 
15μl of 95% ethanol, respectively) (Fig. 14B-E).  All control embryos showed the expected 
expression pattern described in previous studies (Fig. 14B & D) (Deimling and Drysdale, 
2009; Rankin et al., 2012).  Embryos in which Shh signalling was activated showed no 
significant change in staining localization when compared to the control embryos (Fig. 
14D & E).  However, when Shh signalling was inhibited, the embryos displayed a 
significant dorsal shift in the hand1 staining localization with respect to morphological 
landmarks when compared to the control embryos (t (127) = -2.64, p<0.05) (Fig. 14B, C 
& F; Supplementary Figure 1).  Therefore, the distance between the bottom of the cardiac 
cavity and the top of the staining increased for embryos treated with cyclopamine.  The 
dorsal shift of hand1 expression when Shh signalling was inhibited supported the 
hypothesis that presence of Shh signalling results in restriction of the expression domain 
of hand1 in the developing pharyngeal region. 
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Figure 14.   Inhibiting Shh signalling resulted in a dorsal shift of hand1 expression 
within the developing pharyngeal region.  (A) Schematic diagram depicting the 
localization of hand1 expression in the developing pharyngeal region with lines 
demonstrating where markers were placed.  Hand1 is expressed in the broad ventral region 
of the developing pharyngeal region (B & D).  Activating Shh signalling by exposing the 
embryos to purmorphamine resulted in no significant difference in localization of hand1 
expression (E) compared to the control embryos (D).  Inhibition of Shh signalling by 
exposing embryos to cyclopamine resulted in a significant dorsal shift of the hand1 
expression domain (C) when compared to control embryos (B) (t (127) = -2.64, p<0.05).  
Significant differences between the control and treated embryos are marked with an 
asterisk (P < 0.05) according to the two-sample t-test assuming equal variance (F).  EtOH 
– ethanol, PMA – purmorphamine, and CY – cyclopamine. 
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     To further test the hypothesis that Shh signalling regulates the dorsoventral patterning 
of the developing pharyngeal region, genes that are expressed in the intermediate section 
were examined under conditions of altered Shh signalling.  The genes whose expression 
domains were examined were gcm2, and pax1.  The expression of gcm2 is solely 
restricted to the intermediate region of the 2nd, 3rd, and 4th pharyngeal arches during 
embryonic development (Fig. 15A, B & D) (Lee et al., 2013).  Expression of pax1 is 
observed in somites, however, its prominent expression in the first five of the pharyngeal 
arches will be the subject of analysis when examining the dorsoventral patterning of the 
developing pharyngeal region (Fig. 15F, G & I) (Sánchez and Sánchez, 2013).  All 
embryos exposed to the vehicle controls showed the expected staining pattern (Fig. 15B, 
D, G & I) (Lee et al., 2013; Sánchez and Sánchez, 2013).  Embryos exposed to 
purmorphamine showed no significant changes in localization of gcm2 expression when 
compared to the control embryos (Fig. 15D, E & K). Inhibition of Shh signalling resulted 
in embryos that displayed a significant dorsal shift in the gcm2 expression domain when 
compared to control embryos (t (59) = -3.94, p<0.05) (Fig. 15B, C & K; Supplementary 
Figure 2).  Thus, the distance between the bottom of the cardiac cavity and the middle of 
the staining had increased in embryos treated with cyclopamine compared to the control 
embryos.  However, neither purmorphamine or cyclopamine exposure to embryos caused 
any significant shift in the expression of intermediate marker, pax1, along the 
dorsoventral axis of the developing pharyngeal region compared to controls embryos 
(Fig. 15G-J & K).  Interestingly when inhibiting the Shh signalling pathway there was a 
sharp decrease in the number of embryos that express pax1 in the 5th pharyngeal arch. 
This observation will be discussed further in a later section (Fig. 15G & H). 
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Figure 15.  Inhibiting Shh signalling resulted in a dorsal shift in the expression domain 
of the intermediate marker, gcm2 but not pax1, within the developing pharyngeal 
region.  (A & F) Schematic diagrams depicting the localization of gcm2 and pax1 staining 
with lines demonstrating where markers were placed. The gcm2 expression domains are 
restricted to the intermediate region of the 2nd, 3rd, and 4th pharyngeal arches (B & D), 
while, pax1 expression is observed in the first five of the pharyngeal arches (G & I).  
Exposing embryos to purmorphamine did not result in any significant difference in the 
localization of gcm2 (E) or pax1 (J) expression compared to control embryos (D & I).  
Exposing embryos to cyclopamine resulted in a significant dorsal shift of the expression 
domain of gcm2 (C) when compared to the control embryos (B) (t (59) = -3.94, p<0.05).  
Whereas inhibiting Shh signalling resulted in no significant difference in localization of 
pax1 (G) staining compared to the control embryos (H).  Significant differences between 
the control and treated embryos are marked with an asterisk (P < 0.05) according to the 
two-sample t-test assuming equal variance (K).  The sharp decrease in the number of 
embryos that express pax1 in the 5th pharyngeal arch is exemplified when comparing (G) 
and (H).  EtOH – ethanol, PMA – purmorphamine, and CY – cyclopamine. 
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     Genes that are expressed in the dorsal portion of the developing pharyngeal region 
include hoxa3, prrx2, and pou3f3 and these were next examined for changes in their 
expression domain following the manipulation of the Shh signalling pathway.  During the 
development of X. laevis embryos, hoxa3 is expressed in the hindbrain and spinal cord, 
however, my analysis focuses on the hoxa3 expression surrounding the 3rd and 4th 
pharyngeal arches for assessing the dorsoventral patterning of the developing pharyngeal 
region (Fig. 16A, B & D) (McNulty et al., 2005; Square et al., 2015).  Prrx2 expression is 
observed in the mouth primordium and is expressed in the ventral portion of the developing 
pharyngeal region (El-Hodiri and Kelly, 2018; Square et al., 2015).   However, the  focus 
of my analysis is the expression in the dorsal region of the developing pharyngeal complex 
(Fig. 16F, G & I) (Square et al., 2015).  Expression of pou3f3 is localized to the anterior 
neural fold, fore- and hindbrain, and the developing kidney (Cosse-Etchepare et al., 2018; 
Square et al., 2015).  My analysis concentrates on the expression in the first, and second 
pharyngeal arches and was used to assess the dorsoventral patterning of the developing 
pharyngeal region (Fig. 16K, L & N) (Cosse-Etchepare et al., 2018; Square et al., 2015).   
     All embryos treated with the vehicle controls (3µL of DMSO or 3μl of 95% ethanol) 
showed the expected staining profiles (Fig. 16B, D, G, I, L, N & P) (Cosse-Etchepare et 
al., 2018; El-Hodiri and Kelly, 2018; Lee et al., 2013; Square et al., 2015).  The 
examination of the expression domains of hoxa3, and prrx2 of embryos following 
treatment with purmorphamine resulted in no significant change in expression domains 
when compared to the vehicle controls (Fig. 16D, E, I, J & P).  In contrast, significant 
ventral shift in the expression domain of pou3f3 gene were observed when treated with 
purmorphamine compared to the expression pattern of control embryos (t (64) = 2.60, 
p<0.05) (Fig. 16N, O & P; Supplementary Figure 5).  Hence, there was a reduced 
distance between the cardiac cavity and the top of the pou3f3 staining limit in embryos 
treated with purmorphamine.  There was no significant change in the expression domain 
of hoxa3, prrx2 and pou3f3 in embryos when treated with cyclopamine compared to 
vehicle controls (Fig. 16B, C, G, H, L, M & P).  These observations suggest that altering 
Shh signalling may be one of several signalling pathways regulating the dorsoventral 
patterning of the dorsal region of the developing pharyngeal complex.  
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Figure 16.  Pharmacological activation of Shh signalling caused a ventral shift in the 
expression of the dorsal marker, pou3f3, in the developing pharyngeal region.  (A, F 
& K) Schematic diagrams depicting the localization of hoxa3, prrx2, and pou3f3 staining 
with lines demonstrating where markers were placed.  The hoxa3 expression domain 
surrounds the 3rd and 4th pharyngeal arches (B & D), while, the prrx2 expression is 
observed in the ventral portion of the developing pharyngeal region, but the focus of my 
analysis is the expression in the dorsal region of the developing pharyngeal complex (G & 
I), and pou3f3 is expressed in first, and second pharyngeal arches (L & N).  Activating Shh 
signalling by exposing embryos to purmorphamine resulted in no significant difference in 
the expression domain of hoxa3 (E) and prrx2 (J) compared to control embryos (D & I).  
Activating the Shh signalling pathway resulted in a significant ventral shift of pou3f3 (O) 
staining when compared to controls (N) (t (64) = 2.60, p<0.05).  Inhibition of Shh 
signalling, by exposing the embryos to cyclopamine, resulted in no significant change of 
the hoxa3 (C), prrx2 (H), and pou3f3 (M) expression domains when compared to the 
control embryos (B, G & L).  Significant differences between the control and treated 
embryos are marked with an asterisk (P < 0.05) according to the two-sample t-test assuming 
equal variance (P).  EtOH – ethanol, PMA – purmorphamine, and CY – cyclopamine. 
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3.2 Shh signalling regulated the expression of pax1 in the 5th pharyngeal arch 
      Further to my observations in Fig. 15, I observed that when Shh signalling was 
inhibited that the staining of pax1 was lost in the 5th pharyngeal arch.  Embryos that had 
Shh signalling inhibited resulted in only 62.9% (17/27) of the embryos exhibiting staining 
of pax1 in the 5th pharyngeal arch (Fig 17G-I) compared to the control embryos where all 
embryos had expression in the 5th arch (24/24) (Fig 17A-C).  Of those seventeen embryos 
where pax1 expression was detected in the 5th pharyngeal arch, 47% (8/17) displayed a 
reduced pax1 expression domain (Fig 17C-F).  Therefore, Shh signalling is necessary for 
expression of pax1 in the 5th pharyngeal arch during pharyngeal development in X. laevis. 
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Figure 17.  Inhibiting Shh signalling resulted in the loss of expression of pax1 in the 
5th pharyngeal arch.  X. laevis embryos normally express pax1 in the 5th pharyngeal arch 
(24/24) (A-C). X. laevis embryos in which Shh signalling was inhibited resulted in reduced 
(8/27) (D-F) or complete loss (G-I) of pax1 expression in the 5th pharyngeal arch (10/27).   
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3.3 Inhibiting Bmp4 signalling resulted in an abnormal dorsoventral patterning of 
the developing pharyngeal region 
     In the developing neural tube, Shh is opposed by a gradient of Bmp that is necessary to 
achieve proper dorsoventral axis patterning (Briscoe et al., 1999; Liem et al., 2000; Liem 
Jr. et al., 1997; Timmer et al., 2002).  To investigate whether the signaling pathway plays 
a similar role in regulating the dorsoventral patterning of the developing pharyngeal region 
in X. laevis, Bmp4 signalling was inhibited followed by assessment of the same gene 
expression domains analyzed after altering Shh signalling (Jeong et al., 2008; Square et al., 
2015; Talbot et al., 2010). 
    The ventral region of the developing pharyngeal complex that expresses the hand1 gene 
was first examined to investigate whether Bmp4 signalling regulates this pharyngeal 
region.  As noted before the broad staining patterning across the ventral pharyngeal region 
was of interest (Fig. 18A & B).  Bmp4 signalling was inhibited by using either 
dorsomorphin or DHM1 and control embryos were exposed to 3µL of DMSO to control 
for effects of the DMSO vehicle.  Control embryos showed the predicted hand1 expression 
pattern (Fig. 18B) (Deimling and Drysdale, 2009; Rankin et al., 2012).  Embryos treated 
with dorsomorphin displayed no significant change of the hand1 expression domain when 
compared to the control embryos (Fig. 18A & B).  However, embryos exposed to DMH1 
showed a significant ventral shift of the hand1 expression domain when compared to the 
control embryos since a smaller distance was observed between the bottom of the cardiac 
cavity and the top of the staining (F=45.3, P < 0.05) (Fig. 18A & C; Supplementary 
Figure 6). 
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Figure 18.  Inhibiting Bmp4 signalling resulted in a ventral shift of the hand1 
expression domain.  (A) Schematic diagram depicting the expression domain of hand1 in 
the developing pharyngeal region with lines demonstrating where the markers were placed.  
The hand1 gene is normally expressed in the broad ventral region of the developing 
pharyngeal complex (B).  Inhibiting Bmp4 signalling by exposing the embryos to 
dorsomorphin (C) did not change the positioning of the hand1 expression domain along 
the dorsoventral axis, while, DMH1 treatment (D) resulted in a significant ventral shift of 
the hand1 expression domain when compared to control embryos (B) (F=45.3, P < 0.05).  
Significant differences between the control and treated embryos are marked with an 
asterisk (P < 0.05) according to Tukey’s B test (E).  
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     To test if the effect of inhibiting Bmp4 signalling extended to gene expression patterns 
that characterize the intermediate region of the developing pharyngeal complex, the gcm2 
and pax1 expression domains were examined (Fig. 19A & E).  As with the Shh 
experiments, gcm2’s expression in the intermediate region of the 2nd, 3rd, and 4th 
pharyngeal arches (Fig. 19A & B), and pax1’s expression in the first five of the 
pharyngeal arches were the focus of analysis (Fig. 19E & F).  All embryos exposed to 
the vehicle control (3µL of DMSO) displayed the expected staining profiles (Fig. 19B & 
F) (Lee et al., 2013; Sánchez and Sánchez, 2013).  Inhibiting the Bmp4 signalling during 
embryonic development of the pharyngeal region resulted in a significant ventral shift in 
the expression domains of gcm2 when compared to the control embryos (F=10.2, P < 
0.05) (Fig. 19B-D & I; Supplementary Figure 7).  This resulted in a smaller distance 
between the bottom of the cardiac cavity and the midpoint of the staining when Bmp4 
was inhibited.  Exposing the embryos to dorsomorphin did not result in a significant 
change of the pax1 expression domain but inhibiting Bmp4 signalling through the 
application of DMH1 produced a significant ventral shift in the expression domain of 
pax1 when compared to the control embryos (F=3.2, P < 0.05) (Fig. 19F-H & I; 
Supplementary Figure 8).  Consequently, a reduced distance between the bottom of the 
cardiac cavity and midpoint of the staining could be observed when the embryos were 
treated with DMH1.  Unlike the experiments in which Shh signalling was inhibited, pax1 
expression was present in the 5th pharyngeal arch when Bmp4 signalling was inhibited 
demonstrating that Bmp4 is not required for pax1 expression in the 5th pharyngeal (Fig. 
19G & H).  
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Figure 19.  Inhibiting Bmp4 signalling resulted in a ventral shift of the gcm2 and pax1 
expression domain in the developing pharyngeal region.  (A & E) Schematic diagrams 
depict the localization of gcm2 and pax1 staining within the developing pharyngeal region 
with lines demonstrating where markers were placed.  Inhibiting Bmp4 signalling by 
exposing the embryos to dorsomorphin or DMH1 resulted in a significant ventral shift of 
the gcm2 (C & D) when compared to control embryos (B) (F=10.2, P < 0.05).  Inhibition 
of Bmp4 signalling by treating the embryos with DMH1 resulted in a significant ventral 
shift of the pax1 (H) expression domain when compared to controls (F), whereas, treatment 
with dorsomorphin (G) did not reproduce those results (F=3.2, P < 0.05).  Significant 
differences between the control and treated embryos are marked with an asterisk (P < 0.05) 
according to Tukey’s B test (I).  Inhibition of Bmp4 signalling had no effect on pax1 
expression in the 5th pharyngeal arch (G & H) in contrast to what was observed when Shh 
signalling was inhibited. 
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     Finally, I examined the expression domains of hoxa3, prrx2, and pou3f3 that are 
normally expressed in the dorsal region of the developing pharyngeal complex (Fig. 20A, 
E & I).  Embryos treated with the vehicle control (3µL of DMSO) displayed the expected 
expression domains (Fig. 20B, F & J) (Cosse-Etchepare et al., 2018; El-Hodiri and Kelly, 
2018; Lee et al., 2013; Square et al., 2015).  Inhibiting Bmp4 signalling by exposing 
embryos to DMH1 during embryonic development of the pharyngeal region resulted in a 
significant ventral shift of the hoxa3 expression domain when compared to the control 
embryos (F=13.1, P < 0.05) (Fig. 20B, D & M; Supplementary Figure 9).  This ventral 
shift resulted in a smaller distance between the bottom of the cardiac cavity and the top of 
the staining when the embryos were treated with DMH1.  However, treating the embryos 
with dorsomorphin to inhibit Bmp4 signalling did not reproduce the ventral shift of the 
hoxa3 expression domain as observed when the embryos were treated with DMH1 (Fig. 
20B, C & M).  There was no significant change in the expression domain of prrx2 and 
pou3f3 when Bmp4 signalling was inhibited during the development of the pharyngeal 
region when compared to the controls (Fig. 20J-L, F-H & M). 
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Figure 20.  Inhibiting Bmp4 signalling resulted in a ventral shift of the dorsal marker, 
hoxa3.  (A, E & I) Schematic diagrams depicting the localizations of hoxa3, prrx2, and 
pou3f3 expression within the developing pharyngeal region with lines demonstrating where 
markers were placed.  Inhibiting Bmp4 signalling by exposing the embryos to DMH1 
resulted in a significant ventral shift of hoxa3 (D) staining when compared to control 
embryos (B) (F=13.1, P < 0.05).  However, no significant difference was observed between 
the hoxa3 expression domain of control embryos (B) and embryos treated with 
dorsomorphin (C) along the dorsoventral axis.  Inhibiting Bmp4 signalling had no effect 
on the prrx2 and pou3f3 expression domains (G & H, K & L) when compared to control 
embryos (F & J).  Significant differences between the control and treated embryos are 
marked with an asterisk (P < 0.05) according to Tukey’s B test (M). 
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3.4 hand1 played an active role in dorsoventral patterning of the developing 
pharyngeal region 
     In dorsoventral patterning of the neural tube, key transcription factors are expressed at 
different levels along the dorsal ventral axis in response to the Shh and Bmp gradients and 
are necessary for defining specific neuronal fates along that axis (Gowan et al., 2001; 
Persson et al., 2002; Pierani et al., 1999; Timmer et al., 2002).  To test if a similar model 
can be applied to the pharyngeal region, I tested whether hand1 plays an active role in 
patterning the developing pharyngeal region or if it is simply expressed in the ventral 
developing pharyngeal region.  The basic helix-loop-helix transcription factor, hand1, is a 
key player in many development processes, including cardiac and respiratory system 
morphogenesis (Fernandez‐Teran et al., 2003; Hoyos et al., 2016; Rankin et al., 2016).  In 
order to test if hand1 plays an active role, I utilized CRISPR/Cas9 genome editing 
technology to create mutations in the hand1 gene.  The expression domain of the markers 
of the pharyngeal pattern were then compared between control and mutant embryos.   
     To understand the efficiency of hand1 mutagenesis using the CRISPR/Cas9, the target 
regions of the genomic DNA extracted from control or CRISPR/Cas9 injected embryos 
were amplified by PCR and then subjected to a T7 endonuclease assay. As expected, un-
injected embryos showed only a single short hand1 chromosome PCR product (lane #1-5) 
(Fig. 21A) and a single long hand1 chromosome PCR product (Fig. 21B) after the T7 
endonuclease assay.   Therefore, based on the T7 endonuclease assay, 100% (18/18) of the 
un-injected embryos tested did not have any sequence variation present in the long or short 
form of the hand1 chromosome.  CRISPR/Cas9 injected embryos (Fig. 21A & B) 
displayed multiple PCR products demonstrating that a mutation had been introduced at the 
expected site in hand1 chromosome in all embryos injected with the appropriate guide 
RNA and Cas9 protein.  Based on the T7 endonuclease assay, at least one copy of the 
hand1 gene was mutated in 90% (19/21) of the embryos tested. 
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Figure 21. T7E1 assay results demonstrated that CRISPR/Cas9 genome editing was 
successful at causing mutations in the hand1 gene.  (A) Image of hand1s gel with single 
control embryos (lane #1-5) which display a single (intact) band indicating no sequence 
variations are present in the hand1s. Single injected embryos (lane #6-10) displayed 
multiple (cut) bands indicating that mutations were present in the hand1s.  (B) Image of 
hand1l gel with single control embryos (lane #1-4) which display a single (intact) band 
indicating no mutations were present in the hand1l.  Single injected embryos (lane #5-9) 
displayed multiple (cut) bands indicating that mutations have been introduced into the 
target region of the hand1l. 
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      The hand1 mutants were used to investigate whether hand1 activity is downstream of 
Shh and Bmp4 signalling and in turn plays a role in regulating the intermediate portion of 
the developing pharyngeal complex that expresses gcm2, and pax1 (Fig. 22A & D).  
Control embryos were either not injected or injected with dH2O to control for effects of 
injection with the Cas9 protein and hand1 sgRNA.  All control embryos displayed the 
expected staining profiles (Fig. 22B & E) (Lee et al., 2013; Sánchez and Sánchez, 2013).  
CRISPR/Cas9 injected embryos displayed a significant dorsal shift of their gcm2 
expression domain when compared to the control embryos (F=8.3, P < 0.05) (Fig. 22B, C 
& G; Supplementary Figure 10).  Therefore, a larger distance between the bottom of 
the cardiac cavity and midpoint of the staining could be observed when the hand1 gene 
was mutated in the embryos.  However, there were no changes to the pax1 expression 
domain when comparing the CRISPR/Cas9 injected embryos and controls (Fig. 22E, F & 
G). 
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Figure 22.  Embryos that had hand1 mutated using CRISPR/Cas9 showed a dorsal 
shift in the expression domain of gcm2 but not pax1.  (A & D) Schematic diagrams 
depicting the normal expression domain of gcm2 and pax1 in the pharyngeal region with 
lines demonstrating where markers were placed.  Mutating hand1 using CRISPR/Cas9 
technology resulted in a significant dorsal shift of the localization of gcm2 expression 
domain (C) compared to control embryos (B) (F=8.3, P < 0.05).  Mutating hand1 using 
CRISPR/Cas9 technology did not result in any significant difference in expression domain 
of pax1 (F) when compared to control embryos (E).  Significant differences between the 
control and treated embryos are marked with an asterisk (P < 0.05) according to Tukey’s 
B test (G). 
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      Finally, the expression domain of the dorsal marker, prrx2, of the pharyngeal pattern, 
was compared between hand1 mutants and control embryos (Fig. 23).  The expression of 
prrx2 which is restricted to the dorsal region of the developing pharyngeal complex was 
subject to analysis to determine if hand1 indeed regulated the dorsoventral patterning of 
the developing pharyngeal complex downstream of Shh and Bmp4. (Fig. 23A).  All non-
injected, and dH2O-injected embryos showed expected staining profiles (Fig. 23B) (Cosse-
Etchepare et al., 2018; El-Hodiri and Kelly, 2018; Lee et al., 2013; Square et al., 2015).  
The embryos which had hand1 mutated displayed no significant change in the prrx2 
expression domain when compared to the non-injected and dH2O-injected embryos (Fig. 
23B, C & D). 
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Figure 23. Mutations in hand1 resulted in no change of the dorsal marker, prrx2, 
expression domain within the developing pharyngeal region.  (A) Schematic diagrams 
depicting the expression domain of prrx2 with lines demonstrating where markers were 
placed.  Mutating the hand1 gene resulted in no significant difference in the expression 
domain of prrx2 (C) compared to non-injected and H2O-injected embryos (B).  Significant 
differences between the control and treated embryos are marked with an asterisk (P < 0.05) 
according to Tukey’s B test (D). 
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Chapter 4: Discussion 
     The purpose of this thesis was to test the hypothesis that the correct dorsoventral gene 
expression pattern observed in the developing pharyngeal region is regulated by opposing 
gradients of Shh and Bmp4 signalling in X. laevis. I was able to demonstrate gene 
expression pattern changes in response to altered Shh and Bmp4 signalling that supported 
the central hypothesis.  In addition, I tested whether one of the genes whose expression, 
changed, hand1, played a role in the establishing the pattern as well.  During the process 
of analyzing the changes in pax1 expression domains, I was also able to demonstrate that 
Shh is necessary for the expression of pax1 in the 5th pharyngeal arch.  In these following 
sections, I will discuss how my results support my central hypothesis and the findings that 
pax1 expression in the 5th pharyngeal arch requires Shh.  I will also discuss future 
experiments that could further advance our knowledge of how specific signalling pathways 
regulate craniofacial morphogenesis and patterning. 
4.1 Shh signalling regulates the dorsoventral patterning of the developing pharyngeal 
region 
     The first evidence that supports the hypothesis that Shh signalling regulates the 
dorsoventral patterning of the developing pharyngeal region is the shift in the expression 
domain of genes that are differentially expressed within the developing pharyngeal region 
when Shh signalling was either activated or repressed.  Comparison of the position of the 
expression domains as related to established morphological landmarks strongly supports 
the hypothesis that the correct dorsoventral gene expression pattern observed in the 
developing pharyngeal region is regulated by Shh signalling.  Inhibiting Shh signalling 
resulted in the predicted dorsal shift of the hand1 expression domain on the ventral side of 
the embryo, and the gcm2 expression domain in the intermediate region suggesting that 
Shh restricts their expression. In the dorsal region activating Shh signalling resulted in a 
ventral shift of the pou3f3 expression domain suggesting that Shh supports pou3f3 
expression (Fig. 14-16).   
     The changes observed are consistent with a model of Shh and Bmp4 gradients similar 
to those observed in the dorsoventral patterning of the neural tube (Ericson et al., 1996; 
Roelink et al., 1995; Sander et al., 2000).  I predict that similarly to the dorsoventral 
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patterning of the neural tube, Shh signalling molecules are found in a gradient along the 
developing pharyngeal region, where higher levels are observed near the dorsal pole with 
decreasing levels towards the ventral-most region (Ericson et al., 1996; Koide et al., 2006; 
Roelink et al., 1995; Sander et al., 2000).  Cells along the dorsoventral axis of the 
developing pharyngeal region are exposed to varying levels of the Shh ligand that provides 
positional information that then results in either activation or repression of transcription 
factors. Increasing or decreasing the signal that the cells receive results in incorrect 
positional information causing an overall shift of the expression domain of genes along the 
dorsoventral axis of the developing pharyngeal region. 
     One set of data that did not match my predicted outcomes was the lack of significant 
ventral or dorsal shift of the pax1 expression domain in the intermediate region of the 
developing pharyngeal complex (Fig. 15).  One explanation is that its broad expression 
profile, which spans the entire developing pharyngeal region, requires both manipulation 
of Shh and Bmp4 signalling pathways for a significant shift of its expression domain.  The 
pax1 expression spans the complete dorsoventral axis of the developing pharyngeal region, 
it is less susceptible to the loss of one of the two signalling pathways since cells expressing 
the pax1 gene are be exposed to a broad range of Shh or Bmp signal in normal embryos.  
Therefore, to test this hypothesis embryos should be exposed to an activator of the Shh 
signalling pathway and an inhibitor of the Bmp4 signalling pathway to determine if 
manipulation of both signalling pathways is required for a significant shift of the pax1 
expression domain in the ventral direction of the developing pharyngeal region. 
     Pharmacologically activating Shh signalling resulted in a significant ventral shift of the 
pou3f3’s expression domain, while no changes in the expression domains of hand1, gcm2 
or pax1, hoxa3, or prrx2 were observed (Fig. 14-16).  One possible explanation for the 
lack of an observable ventral shift of the hand1 gene expression domain in the ventral 
region and gcm2 and pax1 expression domains located in the intermediate region is that 
the Shh ligand source is dorsal to the developing pharyngeal complex.  Increasing the 
signalling could have an effect at the close proximity in the dorsal region expressing pou3f3 
but fails to change the levels of Shh ligand received by cells in the intermediate region and 
farther ventral regions resulting in no ventral shift of expression domains along the 
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dorsoventral axis of the developing pharyngeal region.  Removing the Shh signal has much 
more of a pronounced effect since there is a threshold below which genes start to be 
regulated differently.  The lack of a ventral shift when pharmacologically activating Shh 
by purmorphamine of the hand1, gcm2, pax1, hoxa3 and prrx2 expression domains could 
also be explained by a threshold with respect to the amount of Shh ligand that cells can 
receive regarding their positional information.  Therefore, cells can be exposed to 
abnormally high levels of the Shh ligand but this excessive amount of the ligand may not 
affect how the cells perceive their location along the dorsoventral axis.  Experiments could 
be conducted to determine if spatial separation between the source of the Shh ligand and 
the Shh sensitive cells is causing no shift in the dorsoventral patterning of the ventral and 
intermediate regions when activating the Shh signalling. 
     As well, the lack of significant dorsal shift of the hoxa3 and prrx2 expression domains 
within the developing pharyngeal region can be explained by comparing it to the patterning 
of the neural tube (Fig. 16).  The proper dorsoventral patterning of the neural tube requires 
the three signalling ligands Shh, Wnt, and Bmp (Le Dréau and Martí, 2012).  The patterning 
of the developing pharyngeal region may also require multiple signalling ligands.  Solely 
inhibiting Shh signalling was not sufficient to cause a shift in the expression domains of 
the hoxa3 and prrx2 and to do so may require at least one more signalling pathway to be 
altered.  To confirm this concept, experiments simultaneously altering Shh and other 
pathways must be conducted to determine if altering multiple signaling pathways is 
necessary to cause the change in the localization of the hoxa3 and prrx2 expression 
domains.  Another experiment that could be conducted would be to isolate tissue from 
dorsal and ventral regions of  the developing pharyngeal complex and to perform RNA 
sequencing from that tissue.  Following the sequencing, any differentially expressed genes 
that have been previously demonstrated to be involved in patterning could represent 
potential signalling molecules (eg. wnt) that by altering could determine if they are 
involved in regulating the patterning of the developing pharyngeal region as well. 
     Lastly, it may be noted that the ethanol and DMSO controls are not significantly 
different from one another except for when analyzing the hoxa3, and pou3f3 expression 
domains.  This is consistent with the previous findings that the expression domains are not 
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always 100% consistent and can vary slightly between embryos and replications of the 
experiments potentially causing the difference in measurement averages between the two 
controls. 
     In summary, my results support the hypothesis that Shh signalling contributes to the 
correct dorsoventral gene expression pattern observed in the developing pharyngeal region. 
4.2 Bmp4 signalling regulates the dorsoventral patterning of the developing 
pharyngeal region 
     The ventral shifts observed in the hand1, gcm2, pax1, and hoxa3 expression domains 
when Bmp4 was broadly and specifically inhibited supported the hypothesis that the 
correct dorsoventral gene expression pattern observed in the developing pharyngeal region 
is regulated by Bmp4 signalling in X. laevis.  As well, the ventral shift of all these 
expression domains also supported the prediction that Bmp4 signalling would support 
ventral expressing regions and suppress dorsal expressing regions.  Either broadly or 
specifically inhibiting Bmp4 signalling resulted in a ventral shift of the hand1 expression 
domain, the intermediate region which expresses the gcm2, and pax1 genes, and the dorsal 
region which expresses the hoxa3 gene within the developing pharyngeal region (Fig. 17-
19).  Similar to the Shh results these ventral shifts fit with a model of Shh and Bmp4 
signalling acting as opposing gradients to pattern the dorsoventral axis as seen in the neural 
tube (Liem Jr. et al., 1995, 1997; Nguyen et al., 2000; Rankin et al., 2012; Timmer et al., 
2002).   
     Within the developing pharyngeal region there is a high concentration of the Bmp4 
ligand near the ventral pole (Rankin et al., 2012).  Moving away from the ventral pole, cells 
are exposed to lower concentrations of the Bmp4 ligand.  This gradient provides cells with 
positional information along the dorsoventral axis resulting in expression or repression of 
key developmental genes (Liem Jr. et al., 1995, 1997; Nguyen et al., 2000; Rankin et al., 
2012; Timmer et al., 2002).  Inhibiting Bmp4 signalling results in cells perceiving that they 
are in a more ventral position compared to their normal position along the dorsoventral 
axis resulting in a ventral shift of the expression domains of the genes of interest (Fig. 17-
19).   
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     The expression domains of prrx2 and pou3f3 did not display a ventral shift when Bmp4 
signalling was inhibited (Fig. 19).  One explanation for this result is that the expression 
domain of prrx2 and pou3f3 genes are located in the most dorsal region.  Inhibiting Bmp4 
signalling may have little to no effect on the most dorsal region of the developing 
pharyngeal complex since limited levels of Bmp4 may reach the dorsal area.  Shh signalling 
may play a stronger role in the dorsoventral patterning of the dorsal region because the 
cells are closer to the Shh ligand source.  The high levels of Bmp4 signalling on the ventral 
side explains why the most dramatic ventral shift was observed in the expression of hand1 
(Fig. 18). 
     Finally, I would like to address the ventral shift of the hand1, pax1 and hoxa3 expression 
domains when treated with DMH1 but not when treated with dorsomorphin (Fig. 18-20).  
This difference between the treatment groups can be attributed to the fact that DMH1 is a 
much more selective and effective inhibitor of Bmp4 signalling.  Differences in results 
between dorsomorphin and DMH1 have previously been observed (Ao et al., 2012).  Cells 
treated with dorsomorphin also had delayed expression profiles when compared to cells 
treated with DMH1 (Ao et al., 2012).   
      In conclusion, these results support the hypothesis that the correct dorsoventral gene 
expression pattern observed in the developing pharyngeal region is regulated by Bmp4 
signalling. 
4.3 Shh signalling is required for pax1 expression in the 5th pharyngeal arch 
     During assessment of the intermediate region of the developing pharyngeal complex 
which expresses pax1 it became apparent that inhibiting Shh signalling resulted in the 
disappearance of pax1 expression in the 5th pharyngeal arch or alternatively, the loss of 
the 5th pharyngeal arch that expresses pax1 (Fig. 17). This result is not surprising given 
that Shh has been demonstrated to mediate as a dual functioning signalling pathway in 
developing structures such as the eye, and limb (Macdonald et al., 1995; Rodrigues et al., 
2017).  During embryonic development, Shh signalling regulates the patterning of the 
eye, and the expression of pax2, and pax6, while also patterning the limb, and controlling 
the expressing of hoxd13 (Macdonald et al., 1995; Rodrigues et al., 2017).  Interestingly 
Shh has been demonstrated to be crucial for proper development of the 1st pharyngeal 
83 
 
 
arch in mice, however, no observable changes occurred to the 1st pharyngeal arch in my 
experiments (Yamagishi et al., 2006).  The difference between results could possibly be 
attributed to using different model organisms or the different time points at which the 
pharyngeal arches were examined.  As well, when Shh signalling was disrupted in mice, 
similar reduced gene expression in the pharyngeal arches was observed where multiple 
transcription targets were downregulated such as Barx1, goosecoid, and dlx2, as well as, 
downregulated fgf8 signalling (Yamagishi et al., 2006). In addition to patterning the 
dorsal ventral axis of the developing pharyngeal region, the results suggest Shh signalling 
participates in anteroposterior patterning of the developing pharyngeal region.  More 
specifically Shh signaling is required for specification of the 5th pharyngeal arch or 
simply be necessary for expression of pax1 in that arch.  Further experiments will be 
required to determine if Shh signalling is required for pax1 expression in the 5th 
pharyngeal arch or is required for the proper development of the 5th pharyngeal 
arch. One set of experiments that could be conducted would be to examine whether 
expression domains of genes such as emx2, nkx3.2b or nkx3.3 that are located in the 5th 
pharyngeal arch are present following inhibition of Shh signalling. If the expression of 
these genes is observed in the 5th pharyngeal arch, this would suggest that Shh signalling 
solely regulates pax1 expression in the 5th pharyngeal arch. If these genes are also not 
expressed following Shh inhibition, further experiments will be needed to confirm that 
Shh signaling is then regulating the development of the 5th pharyngeal arch.  Another 
series of experiments that could be conducted would be to allow the embryos to develop 
to later stages to determine which pharyngeal derives are missing or malformed due to 
loss of pax1 expression in the 5th pharyngeal arch.  I suspect that derivatives of the 5th 
pharyngeal arch such as laryngeal cartilage, and intrinsic muscles would either fail to 
develop or abnormal morphology would be observed leading to impaired functions of the 
larynx. 
 
4.4 hand1 gene regulates the dorsoventral patterning of the developing pharyngeal 
region downstream of Shh and Bmp4 signalling 
     The hypothesis that the correct dorsoventral gene expression pattern observed in the 
developing pharyngeal region is regulated by the hand1 gene downstream of the Shh and 
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Bmp4 signalling pathways is supported by the shift of the gcm2 expression domain 
following mutation of hand1 gene using CRISPR/Cas9.  As well, the dorsal shift of the 
gcm2 expression domain supports the prediction that mutating the hand1 gene will result 
in a dorsal shift of the expression domain because cells aligned along the dorsoventral axis 
of the developing pharyngeal region may be receiving the incorrect positional information 
causing the misexpression of the gcm2 gene (Fig. 23). 
     Hand1 was selected as a potential regulator of the dorsoventral patterning of the 
developing pharyngeal region because the hand1 expression profile had the most 
significant ventral and dorsal shift in expression localization when Bmp4 and Shh 
signalling were inhibited, respectively.  As well, the expression domain of the hand1 gene 
has been demonstrated to be under the regulation of Shh signaling (Fernandez‐Teran et al., 
2003; McFadden et al., 2002).  Therefore, based on the results from the Shh signaling series 
of experiments and work conducted by Fernandez-Teran and colleagues and McFadden 
and colleagues if hand1is mutated and functions downstream of the Shh signalling pathway 
a dorsal shift of gcm2, pax1, hoxa3, prrx2, and pou3f3 expression domains should be 
observed similarly to the dorsal shifts of the expression domains when Shh signalling was 
inhibited (Fernandez‐Teran et al., 2003; McFadden et al., 2002).  Indeed, a dorsal shift in 
the expression of gcm2 was observed.  As mentioned in the two previous sections the dorsal 
shift of the gcm2 expression domain is due to the incorrect positional information that cells 
are receiving.  Therefore, cells which are dorsal to the normal gcm2 expression localization 
now express gcm2, while cells which normally express gcm2, in the ventral region of the 
gcm2 expression domain now repress gcm2 genes. 
     However, no significant dorsal shift was observed in the expression domain of pax1 or 
prrx2.  Similar to the pharmacological interventions, due to the fact that pax1 broad 
expression domains spans the entire dorsoventral axis of the developing pharyngeal region 
manipulating both the Shh and Bmp4 signals may be required to cause a shift of the pax1 
expression domain.  Manipulating either the Shh or Bmp4 signalling pathway failed to 
result in a shift of the pax1 expression domain since its expression is throughout the 
developing pharyngeal region. Thereby, allowing the unmanipulated signalling pathway to 
maintain proper dorsoventral patterning when the other signalling system is either 
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pharmacologically activated or inhibited.  Additionally, the hoxa3, and pou3f3 staining 
localization were trending in the dorsal shift direction similarly to when the hand1 gene 
was mutated and embryos were stained for gcm2, however, more replicates of the 
experiments need to be conducted to statistically confirm that potential dorsal shift 
(Supplementary Figure 9). 
     No significant change in the localization along the dorsoventral axis of the developing 
pharyngeal region of the pax1 and prrx2 expression domains results are explained by my 
previous experiments investigating whether Shh regulates the patterning of the regions 
expressing pax1 and prrx2.  Those experiments demonstrated that the regions expressing 
pax1 and prrx2 are regulated independently from Shh and Bmp4, therefore, it is not 
surprising that mutating the hand1 gene had no effect.  During the development of the 
neural tube Shh, Bmp4, and Wnt signalling are required for the proper dorsoventral 
patterning (Le Dréau and Martí, 2012).  Therefore, Wnt or other signalling molecules could 
be regulating the dorsoventral patterning of the developing pharyngeal region as well.  
Manipulating just one of the signalling pathways or one of the transcription factors 
functioning downstream of these signalling pathways may not have a significant effect on 
the localization of pax1 and prrx2 expression domains (Le Dréau and Martí, 2012; 
Megason and McMahon, 2002).  To test this hypothesis, multiple signalling pathways and 
transcription factors should be manipulated to observe if any significant changes to pax1 
and prrx2 domains occurs along the dorsoventral axis.   
       Overall, the dorsal shift in gcm2 expression domain resulting from mutating the hand1 
gene supports the hypothesis that the correct dorsoventral gene expression pattern observed 
in the developing pharyngeal region is regulated by the hand1 gene downstream of Shh 
and Bmp4 signalling in X. laevis. 
4.5 Future investigations of signalling pathways which regulate craniofacial 
morphogenesis and patterning 
     In this thesis, I have shown that Shh and Bmp4 play a role in the normal dorsoventral 
patterning of the developing pharyngeal region.  These signalling pathways were either 
pharmacologically activated or inhibited, prior to the onset of pharyngeal development 
(stage 13) until stage 35 when the embryos were fixed, and pharyngeal gene expressions 
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were examined.  Hence, this thesis determined the broad window of development where 
appropriate expression levels of the signalling ligands are needed for proper dorsoventral 
patterning.  Using similar methods, it was established that Shh is required for the 
specification of the mouth size and that Shh is mandatory at later tadpole stages for 
perforation of the mouth (Tabler et al., 2014).  Jacqueline Tabler and associates likewise 
first determined a broad window in which Shh signalling was required for proper mouth 
formation and then further refined the exact developmental timeframe when Shh signalling 
was required.  Therefore, future studies could better define a specific developmental 
window where Shh and Bmp4 signalling are required for the dorsoventral patterning of the 
developing pharyngeal region. 
     If my central hypothesis is correct, a clear prediction would be that there should be a 
more substantial shift in the pharyngeal pattern if the Shh signalling pathway is activated 
while the Bmp4 signalling pathway is inhibited during the development and patterning of 
the pharyngeal region.  Activation of Shh and inhibition of Bmp4 concurrently may yield 
a more substantial shift of genes along the dorsoventral axis since both signalling pathways 
are being manipulated.  I would predict that following treatment there would be a more 
substantial ventral shift of the hand1, gcm2, pax1, hoxa3, prrx2 and pou3f3 expression 
domains along the dorsoventral axis since both signalling gradients are being disrupted 
compared to the one signalling gradient that is being disrupted in the present experiments. 
     The third set of experiments that could continue the work of this thesis would be to 
investigate the later morphological consequences of disrupting the normal expression of 
hand1, gcm2, pax1, hoxa3, prrx2, and pou3f3 along the dorsoventral axis of the developing 
pharyngeal region.  The main reason why the genes analyzed in this thesis were chosen 
was that their expression is restricted to specific areas of the developing pharyngeal region 
that allowed me to simplify the analysis of the dorsoventral patterning into three broad 
regions.  A second reason why these genes were selected was that they are crucial in the 
later stages of craniofacial development (Berge et al., 1998; Firulli et al., 2014; Günther et 
al., 2000; Jeong et al., 2008; Liu et al., 2007; Manley and Capecchi, 1998; Su et al., 2001).  
With regard to the ventral region of the developing pharyngeal complex, proper expression 
and phosphoregulation of hand1 are crucial for craniofacial morphogenesis, and when 
hand1 is mutated prominent mid-facial clefts are observed as well as an increase in cell 
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death within the pharyngeal arches (Firulli et al., 2014).  Previous studies have also 
demonstrated that the proper expression of gcm2, and pax1 are crucial for the proper 
formation of the thymus and parathyroid (Günther et al., 2000; Liu et al., 2007; Su et al., 
2001).  Embryos in which the gcm2 gene was mutated resulted in the parathyroid glands 
failing to form, and when the pax1 gene was misexpressed embryos displayed defects in 
the morphology of both organs, incomplete separation of the organs from the pharyngeal 
pouch, and increased cell death during the earlier stages of organogenesis (Günther et al., 
2000; Liu et al., 2007; Su et al., 2001).  Finally, with respect to the hoxa3, prrx2 and pou3f3 
genes chosen as markers for the dorsal region of the developing pharyngeal complex, they 
have been shown to be crucial for the proper development of the thymus, thyroid, 
parathyroid, and bones of the facial region (Berge et al., 1998; Jeong et al., 2008; Manley 
and Capecchi, 1998).  When the hoxa3 gene is silenced embryos display phenotypic defects 
in the thyroid and the parathyroid such as decreased number of C cells in the thyroid lobes 
(Manley and Capecchi, 1998).  Whereas knocking out the expression of both the prrx1 and 
prrx2 genes resulted in multiple phenotypic defects in the craniofacial region.  These 
include shortened dentaries, cleft mandible, and defects around the nasal cavity such as 
cleft palate later causing respiratory issues in the mice (Berge et al., 1998).  When pou3f3 
was knocked out in mice embryos, a significant reduction in the size of the squamosal bone, 
jugal bone, as well as the failure of the stapes to detach from the styloid process were all 
observed (Jeong et al., 2008).  Consequently, disrupting the dorsoventral patterning of 
these genes in the developing pharyngeal region would expect to cause these phenotypic 
defects since all of the aforementioned abnormally developed elements originate from the 
pharyngeal region during embryonic development.  Therefore, bright-field microscopy and 
Alizarin red staining could be used to examine bone and cartilage of X. laevis embryos 
allowed to develop to later tadpole stages. Specific markers for structures such as the 
thyroid and parathyroid could be utilized to determine if disrupting the expression domains 
of these genes along the dorsoventral axis of the developing pharyngeal region will result 
in abnormal phenotypes previously documented. 
4.6 Conclusions 
     Understanding the signalling pathways and transcription factors which regulate the 
developing pharyngeal region along the dorsoventral axis is necessary to understand 
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craniofacial development especially the more developmentally complex structures such as 
the pharynx.  This thesis has uncovered evidence that the Shh and Bmp4 patterning system 
similar to the well-established patterning in the neural tube is used to also regulate the 
dorsoventral axis of the developing pharyngeal region.  Additionally, this thesis implies a 
mechanism that links the pathways and known results of craniofacial development.  The 
first major product of this thesis is the demonstration that Shh and Bmp4 signalling regulate 
the dorsoventral patterning of the developing pharyngeal region in X. laevis during stages 
13 to 35, and secondly that hand1 is a regulator of the patterning downstream of the 
signalling ligands.  Finally, this research has also identified Shh signalling as a regulator 
of pax1 expression in the 5th pharyngeal arch.  Further investigation will be needed to 
determine the exact windows at which Shh, and Bmp4 signalling, and the hand1 gene are 
required for proper dorsoventral patterning of the developing pharyngeal region to advance 
our knowledge of craniofacial development in X. laevis. 
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Appendix: Early X. laevis Embryogenesis 
  
Stage 1 (egg), ventral view 
0 mn pf @ 23°C 
Stage 3 (4-cell), dorsal-lateral view 
2 hr pf @ 23°C 
Stage 13, posterior-dorsal view 
14 hr 45 min pf @ 23°C 
Stage 35-36, lateral view 
2 days, 2 hr pf @ 23°C 
*All images were obtained from www.xenbase.org, according to Nieuwkoop and Faber’s 
Normal Table of Xenopus laevis (Daudin, 1994); Images are morphological 
representations and not drawn to scale 
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Supplementary Figure 1.  Images demonstrating that inhibiting Shh signalling 
resulted in a dorsal shift of hand1 expression within the pharyngeal region.  Inhibition 
of Shh signalling by exposing embryos to cyclopamine resulted in a significant dorsal shift 
of the hand1 expression domain when compared to control embryos.  Arrows indicate 
hand1 expression of interest within the pharyngeal region. 
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Supplementary Figure 2.  Images showing inhibition of Shh signalling resulted in a 
dorsal shift in the expression domain of the intermediate marker gcm2 within the 
developing pharyngeal region.  Exposing embryos to cyclopamine resulted in a 
significant dorsal shift of the expression domain of gcm2 when compared to the control 
embryos.  Arrows indicate gcm2 expression of interest within the pharyngeal region. 
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Supplementary Figure 3. Images demonstrating that altering the Shh signalling 
pathway caused a shift of pou3f3 expression along the dorsoventral axis of the 
developing pharyngeal region. Exposing the embryos with purmorphamine results in a 
significant ventral shift of the expression domain of pou3f3 when compared to the control 
embryos.  Arrows indicate pou3f3 expression of interest within the pharyngeal region.  
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Supplementary Figure 4.  Images demonstrating that inhibiting Bmp4 signalling 
resulted in a ventral shift of hand1 expression within the pharyngeal region.   
Inhibition of Bmp4 signalling by exposing embryos to DMH1 resulted in a significant 
ventral shift of the hand1 expression domain when compared to control embryos.  Arrows 
indicate hand1 expression of interest within the pharyngeal region. 
  
94 
 
 
Supplementary Figure 5.  Images showing that inhibiting Bmp4 signalling resulted in 
a ventral shift of gcm2 expression within the pharyngeal region.   Inhibition of Bmp4 
signalling by exposing embryos to Dorsomorphin and DMH1 resulted in a significant 
ventral shift of the gcm2 expression domain when compared to control embryos. Arrows 
indicate gcm2 expression of interest within the pharyngeal region. 
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Supplementary Figure 6. Images demonstrating that inhibiting Bmp4 signalling 
resulted in a ventral shift of pax1 expression within the pharyngeal region.   Inhibition 
of Bmp4 signalling by exposing embryos to DMH1 resulted in a significant ventral shift 
of the pax1 expression domain when compared to control embryos. Arrows indicate pax1 
expression of interest within the pharyngeal region. 
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Supplementary Figure 7. Images demonstrating that inhibiting Bmp4 signalling 
resulted in a ventral shift of hoxa3 expression within the pharyngeal region.   
Inhibition of Bmp4 signalling by exposing embryos to DMH1 resulted in a significant 
ventral shift of the hoxa3 expression domain when compared to control embryos.  Arrows 
indicate hoxa3 expression of interest within the pharyngeal region. 
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Supplementary Figure 8.  Images of embryos that had hand1 mutated using 
CRISPR/Cas9 showed a dorsal shift in the expression domain of gcm2.  Mutating 
hand1 using CRISPR/Cas9 technology resulted in a significant dorsal shift of the 
localization of gcm2 expression domain compared to control embryos.  Arrows indicate 
gcm2 expression of interest within the pharyngeal region. 
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Supplementary Figure 9.  Mutations in the hand1 gene resulted in a trending dorsal 
shift of the hoxa3 expression domain.  (A & D) Schematic diagrams depicting the 
expression domains of hoxa3 and pou3f3 with lines demonstrating where markers were 
placed.  Following mutation of the hand1 gene a trending dorsal shift of the hoxa3 
expression domain (C) was observed in comparison to the control embryos (B & G).  No 
observable change of the pou3f3 expression domain (E) was observed in the embryos in 
which the hand1 gene was mutated when compared to the control embryos (F & G).   
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